<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Int Soc Sports Nutr</journal-id><journal-id journal-id-type="iso-abbrev">J Int Soc Sports Nutr</journal-id><journal-title-group><journal-title>Journal of the International Society of Sports Nutrition</journal-title></journal-title-group><issn pub-type="epub">1550-2783</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28572749</article-id><article-id pub-id-type="pmc">5452353</article-id><article-id pub-id-type="publisher-id">172</article-id><article-id pub-id-type="doi">10.1186/s12970-017-0172-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The effect of acute pomegranate extract supplementation on oxygen uptake in highly-trained cyclists during high-intensity exercise in a high altitude environment</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Crum</surname><given-names>Emma May</given-names></name><address><phone>+64211534576</phone><email>E.Crum@massey.ac.nz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Che Muhamed</surname><given-names>Ahmad Munir</given-names></name><address><email>ahmadmunir@usm.my</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Barnes</surname><given-names>Matthew</given-names></name><address><email>M.Barnes@massey.ac.nz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stannard</surname><given-names>Stephen Robert</given-names></name><address><email>S.Stannard@massey.ac.nz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.148374.d</institution-id><institution>School of Sport and Exercise, </institution><institution>Massey University (New Zealand), </institution></institution-wrap>Palmerston North, New Zealand </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2294 3534</institution-id><institution-id institution-id-type="GRID">grid.11875.3a</institution-id><institution>Advanced Medical and Dental Institute, </institution><institution>Universiti Sains Malaysia, </institution></institution-wrap>George Town, Malaysia </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>14</volume><elocation-id>14</elocation-id><history><date date-type="received"><day>19</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>© The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><offsets xml_i="4206" xml_f="4216" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="4227" xml_f="4384" txt_i="22" txt_f="179">Recent research has indicated that pomegranate extract (POMx) may improve performance during aerobic exercise by enhancing the matching of vascular oxygen (O</offsets><sub><offsets xml_i="4389" xml_f="4390" txt_i="179" txt_f="180">2</offsets></sub><offsets xml_i="4396" xml_f="4491" txt_i="180" txt_f="275">) provision to muscular requirements. POMx is rich in ellagitannin polyphenols and nitrates (NO</offsets><sub><offsets xml_i="4496" xml_f="4497" txt_i="275" txt_f="276">3</offsets></sub><offsets xml_i="4503" xml_f="4504" txt_i="276" txt_f="277">
</offsets><sup><offsets xml_i="4509" xml_f="4510" txt_i="277" txt_f="278">−</offsets></sup><offsets xml_i="4516" xml_f="4582" txt_i="278" txt_f="344">), which are both associated with improvements in blood flow and O</offsets><sub><offsets xml_i="4587" xml_f="4588" txt_i="344" txt_f="345">2</offsets></sub><offsets xml_i="4594" xml_f="4727" txt_i="345" txt_f="478"> delivery. Primarily, this study aimed to determine whether POMx improves performance in a cycling time trial to exhaustion at 100%VO</offsets><sub><offsets xml_i="4732" xml_f="4736" txt_i="478" txt_f="482">2max</offsets></sub><offsets xml_i="4742" xml_f="4818" txt_i="482" txt_f="558"> (TTE100%) in highly-trained cyclists. In addition, we investigated if the O</offsets><sub><offsets xml_i="4823" xml_f="4824" txt_i="558" txt_f="559">2</offsets></sub><offsets xml_i="4830" xml_f="4839" txt_i="559" txt_f="568"> cost (VO</offsets><sub><offsets xml_i="4844" xml_f="4845" txt_i="568" txt_f="569">2</offsets></sub><offsets xml_i="4851" xml_f="4958" txt_i="569" txt_f="676">) of submaximal exercise was lower with POMx, and whether any changes were greater at high altitude where O</offsets><sub><offsets xml_i="4963" xml_f="4964" txt_i="676" txt_f="677">2</offsets></sub><offsets xml_i="4970" xml_f="4992" txt_i="677" txt_f="699"> delivery is impaired.</offsets></p></sec><sec><title><offsets xml_i="5014" xml_f="5021" txt_i="701" txt_f="708">Methods</offsets></title><p><offsets xml_i="5032" xml_f="5480" txt_i="709" txt_f="1157">Eight cyclists exercised at three submaximal intensities before completing a TTE100% at sea-level (SEA) and at 1657 m of altitude (ALT), with pre-exercise consumption of 1000 mg of POMx or a placebo (PLAC) in a randomized, double-blind, crossover design. Data were analysed using a three way (treatment x altitude x intensity) or two-way (treatment x altitude) repeated measures ANOVA with a Fisher’s LSD post-hoc analysis. Significance was set at </offsets><italic><offsets xml_i="5488" xml_f="5489" txt_i="1157" txt_f="1158">p</offsets></italic><offsets xml_i="5498" xml_f="5582" txt_i="1158" txt_f="1242"> ≤ 0.05. The effect size of significant interactions was calculated using Cohen’s d.</offsets></p></sec><sec><title><offsets xml_i="5604" xml_f="5611" txt_i="1244" txt_f="1251">Results</offsets></title><p><offsets xml_i="5622" xml_f="5693" txt_i="1252" txt_f="1323">TTE100% performance was reduced in ALT but was not influenced by POMx (</offsets><italic><offsets xml_i="5701" xml_f="5702" txt_i="1323" txt_f="1324">p</offsets></italic><offsets xml_i="5711" xml_f="5733" txt_i="1324" txt_f="1343"> &gt; 0.05). Plasma NO</offsets><sub><offsets xml_i="5738" xml_f="5739" txt_i="1343" txt_f="1344">3</offsets></sub><offsets xml_i="5745" xml_f="5746" txt_i="1344" txt_f="1345">
</offsets><sup><offsets xml_i="5751" xml_f="5752" txt_i="1345" txt_f="1346">−</offsets></sup><offsets xml_i="5758" xml_f="5820" txt_i="1346" txt_f="1408"> were 10.3 μmol greater with POMx vs. PLAC (95% CI, 0.8, 19.7,</offsets><italic><offsets xml_i="5828" xml_f="5829" txt_i="1408" txt_f="1409">F</offsets></italic><offsets xml_i="5838" xml_f="5839" txt_i="1409" txt_f="1410">
</offsets><sub><offsets xml_i="5844" xml_f="5847" txt_i="1410" txt_f="1413">1,7</offsets></sub><offsets xml_i="5853" xml_f="5862" txt_i="1413" txt_f="1422"> = 7.83, </offsets><italic><offsets xml_i="5870" xml_f="5871" txt_i="1422" txt_f="1423">p</offsets></italic><offsets xml_i="5880" xml_f="5895" txt_i="1423" txt_f="1435"> &lt; 0.04). VO</offsets><sub><offsets xml_i="5900" xml_f="5901" txt_i="1435" txt_f="1436">2</offsets></sub><offsets xml_i="5907" xml_f="6013" txt_i="1436" txt_f="1542"> measured at five minutes into the TTE100% was significantly increased in ALTPOMx vs. ALTPLAC (+3.8 ml.min</offsets><sup><offsets xml_i="6018" xml_f="6020" txt_i="1542" txt_f="1544">−1</offsets></sup><offsets xml_i="6026" xml_f="6028" txt_i="1544" txt_f="1546">kg</offsets><sup><offsets xml_i="6033" xml_f="6035" txt_i="1546" txt_f="1548">−1</offsets></sup><offsets xml_i="6041" xml_f="6063" txt_i="1548" txt_f="1570">, 95% CI, −5.7, 9.5, F</offsets><sub><offsets xml_i="6068" xml_f="6071" txt_i="1570" txt_f="1573">1,7</offsets></sub><offsets xml_i="6077" xml_f="6086" txt_i="1573" txt_f="1582"> = 29.2, </offsets><italic><offsets xml_i="6094" xml_f="6095" txt_i="1582" txt_f="1583">p</offsets></italic><offsets xml_i="6104" xml_f="6162" txt_i="1583" txt_f="1641"> = 0.001, ES = 0.6) but unchanged in SEAPOMx vs. SEAPLAC (</offsets><italic><offsets xml_i="6170" xml_f="6171" txt_i="1641" txt_f="1642">p</offsets></italic><offsets xml_i="6180" xml_f="6206" txt_i="1642" txt_f="1665"> &gt; 0.05). Submaximal VO</offsets><sub><offsets xml_i="6211" xml_f="6212" txt_i="1665" txt_f="1666">2</offsets></sub><offsets xml_i="6218" xml_f="6253" txt_i="1666" txt_f="1701"> values were not affected by POMx (</offsets><italic><offsets xml_i="6261" xml_f="6262" txt_i="1701" txt_f="1702">p</offsets></italic><offsets xml_i="6271" xml_f="6280" txt_i="1702" txt_f="1711"> ≥ 0.05).</offsets></p></sec><sec><title><offsets xml_i="6302" xml_f="6313" txt_i="1713" txt_f="1724">Conclusions</offsets></title><p><offsets xml_i="6324" xml_f="6349" txt_i="1725" txt_f="1750">The restoration of SEA VO</offsets><sub><offsets xml_i="6354" xml_f="6355" txt_i="1750" txt_f="1751">2</offsets></sub><offsets xml_i="6361" xml_f="6517" txt_i="1751" txt_f="1907"> values at ALT is likely driven by the high polyphenol content of POMx, which is proposed to improve nitric oxide bioavailability. Despite an increase in VO</offsets><sub><offsets xml_i="6522" xml_f="6523" txt_i="1907" txt_f="1908">2</offsets></sub><offsets xml_i="6529" xml_f="6659" txt_i="1908" txt_f="2038">, no change in exercise performance occurred and therefore this study does not support the use of POMx as an ergogenic supplement.</offsets></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Nitrates</kwd><kwd>Polyphenols</kwd><kwd>Ergogenic aids</kwd><kwd>Exercise performance</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001554</institution-id><institution>Massey University</institution></institution-wrap></funding-source><award-id>Doctoral Scholarship</award-id><principal-award-recipient><name><surname>Crum</surname><given-names>Emma May</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title><offsets xml_i="7512" xml_f="7522" txt_i="2047" txt_f="2057">Background</offsets></title><p><offsets xml_i="7533" xml_f="7546" txt_i="2058" txt_f="2071">Pomegranate (</offsets><italic><offsets xml_i="7554" xml_f="7569" txt_i="2071" txt_f="2086">Punica granatum</offsets></italic><offsets xml_i="7578" xml_f="7726" txt_i="2086" txt_f="2234">) (POM), is a seeded, red, fleshy fruit of Middle East origin which was used in traditional medicine to treat a variety of inflammatory conditions [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="7758" xml_f="7759" txt_i="2234" txt_f="2235">1</offsets></xref><offsets xml_i="7766" xml_f="7882" txt_i="2235" txt_f="2351">]. In modern-day research, the health benefits of POM have been attributed to its high concentration of nitrates (NO</offsets><sub><offsets xml_i="7887" xml_f="7888" txt_i="2351" txt_f="2352">3</offsets></sub><offsets xml_i="7894" xml_f="7895" txt_i="2352" txt_f="2353">
</offsets><sup><offsets xml_i="7900" xml_f="7901" txt_i="2353" txt_f="2354">−</offsets></sup><offsets xml_i="7907" xml_f="8043" txt_i="2354" txt_f="2490">) and polyphenol compounds, and consumption of POM juice (POMJ) or extract (POMx) has been linked to a decline in cancer proliferation [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="8075" xml_f="8076" txt_i="2490" txt_f="2491">2</offsets></xref><offsets xml_i="8083" xml_f="8138" txt_i="2491" txt_f="2546">], the amelioration of cardiovascular disease markers [</offsets><xref ref-type="bibr" rid="CR3"><offsets xml_i="8170" xml_f="8171" txt_i="2546" txt_f="2547">3</offsets></xref><offsets xml_i="8178" xml_f="8225" txt_i="2547" txt_f="2594">] and decreases in gut and joint inflammation [</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="8257" xml_f="8258" txt_i="2594" txt_f="2595">4</offsets></xref><offsets xml_i="8265" xml_f="8267" txt_i="2595" txt_f="2597">, </offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="8299" xml_f="8300" txt_i="2597" txt_f="2598">5</offsets></xref><offsets xml_i="8307" xml_f="8459" txt_i="2598" txt_f="2750">]. Recent research has indicated that POM-based supplements can also improve performance during aerobic exercise by enhancing the matching of vascular O</offsets><sub><offsets xml_i="8464" xml_f="8465" txt_i="2750" txt_f="2751">2</offsets></sub><offsets xml_i="8471" xml_f="8508" txt_i="2751" txt_f="2788"> provision to muscular requirements [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="8540" xml_f="8541" txt_i="2788" txt_f="2789">6</offsets></xref><offsets xml_i="8548" xml_f="8550" txt_i="2789" txt_f="2791">, </offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="8582" xml_f="8583" txt_i="2791" txt_f="2792">7</offsets></xref><offsets xml_i="8590" xml_f="8592" txt_i="2792" txt_f="2794">].</offsets></p><p><offsets xml_i="8599" xml_f="8743" txt_i="2795" txt_f="2939">Polyphenols are a group of phytochemicals with antioxidant properties that contain one or more aromatic rings and at least two hydroxyl groups [</offsets><xref ref-type="bibr" rid="CR8"><offsets xml_i="8775" xml_f="8776" txt_i="2939" txt_f="2940">8</offsets></xref><offsets xml_i="8783" xml_f="8850" txt_i="2940" txt_f="3007">]. POMJ contains a greater concentration of polyphenols (~3.8 mg.ml</offsets><sup><offsets xml_i="8855" xml_f="8857" txt_i="3007" txt_f="3009">−1</offsets></sup><offsets xml_i="8863" xml_f="8930" txt_i="3009" txt_f="3076">) than other polyphenol-rich beverages such as red wine (~3.5 mg.ml</offsets><sup><offsets xml_i="8935" xml_f="8937" txt_i="3076" txt_f="3078">−1</offsets></sup><offsets xml_i="8943" xml_f="8977" txt_i="3078" txt_f="3112">), Concord grape juice (~2.6 mg.ml</offsets><sup><offsets xml_i="8982" xml_f="8984" txt_i="3112" txt_f="3114">−1</offsets></sup><offsets xml_i="8990" xml_f="9023" txt_i="3114" txt_f="3147">) and cranberry juice (~1.7 mg.ml</offsets><sup><offsets xml_i="9028" xml_f="9030" txt_i="3147" txt_f="3149">−1</offsets></sup><offsets xml_i="9036" xml_f="9039" txt_i="3149" txt_f="3152">) [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="9071" xml_f="9072" txt_i="3152" txt_f="3153">9</offsets></xref><offsets xml_i="9079" xml_f="9197" txt_i="3153" txt_f="3271">]. These are predominantly from the ellagitannin (ET) subclass (80–90%) with smaller amounts of anthocyanins (8–15%) [</offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="9230" xml_f="9232" txt_i="3271" txt_f="3273">10</offsets></xref><offsets xml_i="9239" xml_f="9400" txt_i="3273" txt_f="3434">]. Consumption of ET or anthocyanin-rich foods is associated with a decrease in systolic blood pressure (SBP) and an increase in vessel diameter and blood flow [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="9432" xml_f="9433" txt_i="3434" txt_f="3435">6</offsets></xref><offsets xml_i="9440" xml_f="9442" txt_i="3435" txt_f="3437">, </offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="9475" xml_f="9477" txt_i="3437" txt_f="3439">11</offsets></xref><offsets xml_i="9484" xml_f="9486" txt_i="3439" txt_f="3441">, </offsets><xref ref-type="bibr" rid="CR12"><offsets xml_i="9519" xml_f="9521" txt_i="3441" txt_f="3443">12</offsets></xref><offsets xml_i="9528" xml_f="9577" txt_i="3443" txt_f="3492">] suggesting a link between POM consumption and O</offsets><sub><offsets xml_i="9582" xml_f="9583" txt_i="3492" txt_f="3493">2</offsets></sub><offsets xml_i="9589" xml_f="9599" txt_i="3493" txt_f="3503"> delivery.</offsets></p><p><offsets xml_i="9606" xml_f="9637" txt_i="3504" txt_f="3535">Supplementation with dietary NO</offsets><sub><offsets xml_i="9642" xml_f="9643" txt_i="3535" txt_f="3536">3</offsets></sub><offsets xml_i="9649" xml_f="9650" txt_i="3536" txt_f="3537">
</offsets><sup><offsets xml_i="9655" xml_f="9656" txt_i="3537" txt_f="3538">−</offsets></sup><offsets xml_i="9662" xml_f="9675" txt_i="3538" txt_f="3551"> influences O</offsets><sub><offsets xml_i="9680" xml_f="9681" txt_i="3551" txt_f="3552">2</offsets></sub><offsets xml_i="9687" xml_f="9870" txt_i="3552" txt_f="3735"> delivery during exercise through its conversion to the potent vasodilator, nitric oxide (NO). During resting conditions, NO is primarily produced endogenously by NO synthases (NOS) [</offsets><xref ref-type="bibr" rid="CR13"><offsets xml_i="9903" xml_f="9905" txt_i="3735" txt_f="3737">13</offsets></xref><offsets xml_i="9912" xml_f="10092" txt_i="3737" txt_f="3917">]. However, in hypoxic conditions, such as those present locally in the muscles during exercise, activity of this pathway is limited, placing greater importance on the secondary NO</offsets><sub><offsets xml_i="10097" xml_f="10098" txt_i="3917" txt_f="3918">3</offsets></sub><offsets xml_i="10104" xml_f="10105" txt_i="3918" txt_f="3919">
</offsets><sup><offsets xml_i="10110" xml_f="10111" txt_i="3919" txt_f="3920">−</offsets></sup><offsets xml_i="10117" xml_f="10129" txt_i="3920" txt_f="3932">-nitrite (NO</offsets><sub><offsets xml_i="10134" xml_f="10135" txt_i="3932" txt_f="3933">2</offsets></sub><offsets xml_i="10141" xml_f="10142" txt_i="3933" txt_f="3934">
</offsets><sup><offsets xml_i="10147" xml_f="10148" txt_i="3934" txt_f="3935">−</offsets></sup><offsets xml_i="10154" xml_f="10168" txt_i="3935" txt_f="3949">)-NO pathway [</offsets><xref ref-type="bibr" rid="CR14"><offsets xml_i="10201" xml_f="10203" txt_i="3949" txt_f="3951">14</offsets></xref><offsets xml_i="10210" xml_f="10266" txt_i="3951" txt_f="4007">]. Polyphenols further enhance the effects of dietary NO</offsets><sub><offsets xml_i="10271" xml_f="10272" txt_i="4007" txt_f="4008">3</offsets></sub><offsets xml_i="10278" xml_f="10279" txt_i="4008" txt_f="4009">
</offsets><sup><offsets xml_i="10284" xml_f="10285" txt_i="4009" txt_f="4010">−</offsets></sup><offsets xml_i="10291" xml_f="10331" txt_i="4010" txt_f="4050"> by promoting their conversion into NO [</offsets><xref ref-type="bibr" rid="CR15"><offsets xml_i="10364" xml_f="10366" txt_i="4050" txt_f="4052">15</offsets></xref><offsets xml_i="10373" xml_f="10375" txt_i="4052" txt_f="4054">, </offsets><xref ref-type="bibr" rid="CR16"><offsets xml_i="10408" xml_f="10410" txt_i="4054" txt_f="4056">16</offsets></xref><offsets xml_i="10417" xml_f="10491" txt_i="4056" txt_f="4130">], and protecting NO from damage caused by reactive oxygen species (ROS) [</offsets><xref ref-type="bibr" rid="CR17"><offsets xml_i="10524" xml_f="10526" txt_i="4130" txt_f="4132">17</offsets></xref><offsets xml_i="10533" xml_f="10535" txt_i="4132" txt_f="4134">].</offsets></p><p><offsets xml_i="10542" xml_f="10572" txt_i="4135" txt_f="4165">Previous research involving NO</offsets><sub><offsets xml_i="10577" xml_f="10578" txt_i="4165" txt_f="4166">3</offsets></sub><offsets xml_i="10584" xml_f="10585" txt_i="4166" txt_f="4167">
</offsets><sup><offsets xml_i="10590" xml_f="10591" txt_i="4167" txt_f="4168">−</offsets></sup><offsets xml_i="10597" xml_f="10684" txt_i="4168" txt_f="4255"> supplementation has predominantly used beetroot juice (BRJ), which contains ~11 mmol.L</offsets><sup><offsets xml_i="10689" xml_f="10691" txt_i="4255" txt_f="4257">−1</offsets></sup><offsets xml_i="10697" xml_f="10700" txt_i="4257" txt_f="4260"> NO</offsets><sub><offsets xml_i="10705" xml_f="10706" txt_i="4260" txt_f="4261">3</offsets></sub><offsets xml_i="10712" xml_f="10713" txt_i="4261" txt_f="4262">
</offsets><sup><offsets xml_i="10718" xml_f="10719" txt_i="4262" txt_f="4263">−</offsets></sup><offsets xml_i="10725" xml_f="10727" txt_i="4263" txt_f="4265"> [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="10760" xml_f="10762" txt_i="4265" txt_f="4267">18</offsets></xref><offsets xml_i="10769" xml_f="10799" txt_i="4267" txt_f="4297">] in comparison to 12.93 ppm.L</offsets><sup><offsets xml_i="10804" xml_f="10806" txt_i="4297" txt_f="4299">−1</offsets></sup><offsets xml_i="10812" xml_f="10825" txt_i="4299" txt_f="4312"> (~0.2 mmol.L</offsets><sup><offsets xml_i="10830" xml_f="10832" txt_i="4312" txt_f="4314">−1</offsets></sup><offsets xml_i="10838" xml_f="10861" txt_i="4314" txt_f="4337">) in POMJ and 109 ppm.L</offsets><sup><offsets xml_i="10866" xml_f="10868" txt_i="4337" txt_f="4339">−1</offsets></sup><offsets xml_i="10874" xml_f="10888" txt_i="4339" txt_f="4353"> (~1.76 mmol.L</offsets><sup><offsets xml_i="10893" xml_f="10895" txt_i="4353" txt_f="4355">−1</offsets></sup><offsets xml_i="10901" xml_f="10943" txt_i="4355" txt_f="4397">) in POMx, as reported by Roelofs et al. [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="10975" xml_f="10976" txt_i="4397" txt_f="4398">6</offsets></xref><offsets xml_i="10983" xml_f="11125" txt_i="4398" txt_f="4537">]. Acute or short-term BRJ supplementation in low to moderately-trained individuals is associated with a large increase (&gt;92%) in plasma NO</offsets><sub><offsets xml_i="11130" xml_f="11131" txt_i="4537" txt_f="4538">2</offsets></sub><offsets xml_i="11137" xml_f="11138" txt_i="4538" txt_f="4539">
</offsets><sup><offsets xml_i="11143" xml_f="11144" txt_i="4539" txt_f="4540">−</offsets></sup><offsets xml_i="11150" xml_f="11173" txt_i="4540" txt_f="4563">, a 3–5% reduction in O</offsets><sub><offsets xml_i="11178" xml_f="11179" txt_i="4563" txt_f="4564">2</offsets></sub><offsets xml_i="11185" xml_f="11196" txt_i="4564" txt_f="4575"> uptake (VO</offsets><sub><offsets xml_i="11201" xml_f="11202" txt_i="4575" txt_f="4576">2</offsets></sub><offsets xml_i="11208" xml_f="11350" txt_i="4576" txt_f="4718">) during submaximal exercise and a 15–25% improvement in performance during cycling, running and knee extension time to exhaustion protocols [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="11383" xml_f="11385" txt_i="4718" txt_f="4720">18</offsets></xref><offsets xml_i="11392" xml_f="11393" txt_i="4720" txt_f="4721">–</offsets><xref ref-type="bibr" rid="CR22"><offsets xml_i="11426" xml_f="11428" txt_i="4721" txt_f="4723">22</offsets></xref><offsets xml_i="11435" xml_f="11530" txt_i="4723" txt_f="4818">]. In contrast, BRJ has little or no benefit on these parameters in highly-trained athletes (VO</offsets><sub><offsets xml_i="11535" xml_f="11539" txt_i="4818" txt_f="4822">2max</offsets></sub><offsets xml_i="11545" xml_f="11559" txt_i="4822" txt_f="4833"> &gt;60 ml.min</offsets><sup><offsets xml_i="11564" xml_f="11566" txt_i="4833" txt_f="4835">−1</offsets></sup><offsets xml_i="11572" xml_f="11574" txt_i="4835" txt_f="4837">kg</offsets><sup><offsets xml_i="11579" xml_f="11581" txt_i="4837" txt_f="4839">−1</offsets></sup><offsets xml_i="11587" xml_f="11681" txt_i="4839" txt_f="4933">), who may have greater NOS activity and consequently a lower reliance on NO production via NO</offsets><sub><offsets xml_i="11686" xml_f="11687" txt_i="4933" txt_f="4934">3</offsets></sub><offsets xml_i="11693" xml_f="11694" txt_i="4934" txt_f="4935">
</offsets><sup><offsets xml_i="11699" xml_f="11700" txt_i="4935" txt_f="4936">−</offsets></sup><offsets xml_i="11706" xml_f="11708" txt_i="4936" txt_f="4938"> [</offsets><xref ref-type="bibr" rid="CR23"><offsets xml_i="11741" xml_f="11743" txt_i="4938" txt_f="4940">23</offsets></xref><offsets xml_i="11750" xml_f="11751" txt_i="4940" txt_f="4941">–</offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="11784" xml_f="11786" txt_i="4941" txt_f="4943">29</offsets></xref><offsets xml_i="11793" xml_f="11918" txt_i="4943" txt_f="5068">]. However, BRJ appears to benefit these athletes during exercise at high altitude, where the lower atmospheric pressure of O</offsets><sub><offsets xml_i="11923" xml_f="11924" txt_i="5068" txt_f="5069">2</offsets></sub><offsets xml_i="11930" xml_f="11934" txt_i="5069" txt_f="5073"> (PO</offsets><sub><offsets xml_i="11939" xml_f="11940" txt_i="5073" txt_f="5074">2</offsets></sub><offsets xml_i="11946" xml_f="11957" txt_i="5074" txt_f="5085">) impairs O</offsets><sub><offsets xml_i="11962" xml_f="11963" txt_i="5085" txt_f="5086">2</offsets></sub><offsets xml_i="11969" xml_f="12050" txt_i="5086" txt_f="5167"> transport and places greater reliance on the non-aerobic pathway to produce NO [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="12083" xml_f="12085" txt_i="5167" txt_f="5169">30</offsets></xref><offsets xml_i="12092" xml_f="12094" txt_i="5169" txt_f="5171">, </offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="12127" xml_f="12129" txt_i="5171" txt_f="5173">31</offsets></xref><offsets xml_i="12136" xml_f="12273" txt_i="5173" txt_f="5310">]. This is significant because exercise at high altitude features in a number of major sporting competitions, such as the Tour de France.</offsets></p><p><offsets xml_i="12280" xml_f="12317" txt_i="5311" txt_f="5348">While BRJ clearly has an effect on VO</offsets><sub><offsets xml_i="12322" xml_f="12323" txt_i="5348" txt_f="5349">2</offsets></sub><offsets xml_i="12329" xml_f="12401" txt_i="5349" txt_f="5421">, the high concentration of ET in POM may provide a source of dietary NO</offsets><sub><offsets xml_i="12406" xml_f="12407" txt_i="5421" txt_f="5422">3</offsets></sub><offsets xml_i="12413" xml_f="12414" txt_i="5422" txt_f="5423">
</offsets><sup><offsets xml_i="12419" xml_f="12420" txt_i="5423" txt_f="5424">−</offsets></sup><offsets xml_i="12426" xml_f="12483" txt_i="5424" txt_f="5481"> with greater bioavailability, despite the lower total NO</offsets><sub><offsets xml_i="12488" xml_f="12489" txt_i="5481" txt_f="5482">3</offsets></sub><offsets xml_i="12495" xml_f="12496" txt_i="5482" txt_f="5483">
</offsets><sup><offsets xml_i="12501" xml_f="12502" txt_i="5483" txt_f="5484">−</offsets></sup><offsets xml_i="12508" xml_f="12707" txt_i="5484" txt_f="5683"> content. Currently, only two studies have investigated the effect of POM supplementation on endurance exercise performance at sea-level, with no previous research investigating its effects in low PO</offsets><sub><offsets xml_i="12712" xml_f="12713" txt_i="5683" txt_f="5684">2</offsets></sub><offsets xml_i="12719" xml_f="12906" txt_i="5684" txt_f="5871"> conditions. In moderately-trained individuals, acute POMx intake (1000 mg) increased pre-exercise blood flow and time to exhaustion during treadmill running at 90-100% of peak velocity [</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="12938" xml_f="12939" txt_i="5871" txt_f="5872">7</offsets></xref><offsets xml_i="12946" xml_f="13018" txt_i="5872" txt_f="5944">]. Conversely, following seven days of POMJ supplementation (1000 ml.day</offsets><sup><offsets xml_i="13023" xml_f="13025" txt_i="5944" txt_f="5946">−1</offsets></sup><offsets xml_i="13031" xml_f="13181" txt_i="5946" txt_f="6096">) in a trained cohort, no change in performance was observed during a ten minute cycling time trial or time to exhaustion protocol in hot conditions [</offsets><xref ref-type="bibr" rid="CR32"><offsets xml_i="13214" xml_f="13216" txt_i="6096" txt_f="6098">32</offsets></xref><offsets xml_i="13223" xml_f="13297" txt_i="6098" txt_f="6172">]. Thus, further research is warranted to determine whether POM improves O</offsets><sub><offsets xml_i="13302" xml_f="13303" txt_i="6172" txt_f="6173">2</offsets></sub><offsets xml_i="13309" xml_f="13355" txt_i="6173" txt_f="6219"> transport and endurance exercise performance.</offsets></p><p><offsets xml_i="13362" xml_f="13558" txt_i="6220" txt_f="6416">The outcomes of the current study are primarily to further explore the effect of acute POMx supplementation on endurance exercise performance, and secondarily, to determine the effect of POMx on O</offsets><sub><offsets xml_i="13563" xml_f="13564" txt_i="6416" txt_f="6417">2</offsets></sub><offsets xml_i="13570" xml_f="13797" txt_i="6417" txt_f="6644"> transport parameters. In addition, the study will investigate whether any observed effects are greater during exercise in a high altitude environment. We hypothesize that acute POMx supplementation will reduce the submaximal O</offsets><sub><offsets xml_i="13802" xml_f="13803" txt_i="6644" txt_f="6645">2</offsets></sub><offsets xml_i="13809" xml_f="13901" txt_i="6645" txt_f="6737"> cost of exercise, and in doing so, improve performance in an environment (altitude) where O</offsets><sub><offsets xml_i="13906" xml_f="13907" txt_i="6737" txt_f="6738">2</offsets></sub><offsets xml_i="13913" xml_f="13943" txt_i="6738" txt_f="6768"> availability may be limiting.</offsets></p></sec><sec id="Sec2" sec-type="materials|methods"><title><offsets xml_i="14004" xml_f="14011" txt_i="6770" txt_f="6777">Methods</offsets></title><sec id="Sec3"><title><offsets xml_i="14041" xml_f="14053" txt_i="6778" txt_f="6790">Participants</offsets></title><p><offsets xml_i="14064" xml_f="14459" txt_i="6791" txt_f="7186">All participants provided written consent after being informed about the study requirements and benefits and risks of participating. A health questionnaire was also completed. Eight highly-trained cyclists, including seven males and one female, were recruited from the regional cycle community. This sample size was chosen based on previous studies which have successfully shown a decrease in VO</offsets><sub><offsets xml_i="14464" xml_f="14465" txt_i="7186" txt_f="7187">2</offsets></sub><offsets xml_i="14471" xml_f="14484" txt_i="7187" txt_f="7200"> following NO</offsets><sub><offsets xml_i="14489" xml_f="14490" txt_i="7200" txt_f="7201">3</offsets></sub><offsets xml_i="14496" xml_f="14497" txt_i="7201" txt_f="7202">
</offsets><sup><offsets xml_i="14502" xml_f="14503" txt_i="7202" txt_f="7203">−</offsets></sup><offsets xml_i="14509" xml_f="14564" txt_i="7203" txt_f="7258"> supplementation with a sample size of 8 participants [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="14597" xml_f="14599" txt_i="7258" txt_f="7260">18</offsets></xref><offsets xml_i="14606" xml_f="14608" txt_i="7260" txt_f="7262">, </offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="14641" xml_f="14643" txt_i="7262" txt_f="7264">21</offsets></xref><offsets xml_i="14650" xml_f="14951" txt_i="7264" txt_f="7565">]. While the sample size is small, this was unavoidable given the highly-trained status of participants that we wished to study. All participants were current or past members of the national cycling or triathlon junior development programmes. Their age, height, body mass and peak aerobic capacity (VO</offsets><sub><offsets xml_i="14956" xml_f="14960" txt_i="7565" txt_f="7569">2max</offsets></sub><offsets xml_i="14966" xml_f="15031" txt_i="7569" txt_f="7634">) were 17–18 years, 67.6 ± 7 kg, 180 ± 9 cm and 74.4 ± 6.2 ml.min</offsets><sup><offsets xml_i="15036" xml_f="15038" txt_i="7634" txt_f="7636">−1</offsets></sup><offsets xml_i="15044" xml_f="15046" txt_i="7636" txt_f="7638">kg</offsets><sup><offsets xml_i="15051" xml_f="15053" txt_i="7638" txt_f="7640">−1</offsets></sup><offsets xml_i="15059" xml_f="15211" txt_i="7640" txt_f="7792"> respectively. The study was approved by the Massey University Human Ethics Committee (Southern A 15/54) in accordance with the Declaration of Helsinki.</offsets></p></sec><sec id="Sec4"><title><offsets xml_i="15243" xml_f="15262" txt_i="7794" txt_f="7813">Experimental design</offsets></title><sec id="Sec5"><title><offsets xml_i="15292" xml_f="15294" txt_i="7814" txt_f="7816">VO</offsets><sub><offsets xml_i="15299" xml_f="15303" txt_i="7816" txt_f="7820">2max</offsets></sub><offsets xml_i="15309" xml_f="15314" txt_i="7820" txt_f="7825"> test</offsets></title><p><offsets xml_i="15325" xml_f="15413" txt_i="7826" txt_f="7914">In order to determine workloads for the supplemented trials, participants completed a VO</offsets><sub><offsets xml_i="15418" xml_f="15422" txt_i="7914" txt_f="7918">2max</offsets></sub><offsets xml_i="15428" xml_f="16065" txt_i="7918" txt_f="8555"> test in thermoneutral conditions (18–20 °C) at sea-level, on an electronically-braked cycle ergometer (Lode Excalibur Sport, Groningen, The Netherlands), which was set up as closely as possible to the participant’s own bike. This session doubled as an initial familiarization session to ensure participants were familiar with the equipment and protocols involved in the experimental sessions. Following a five minute warm-up at 100 W, participants completed four × 7-min stages of increasing workload (e.g., 150, 200, 250, 300 W) with expired air being collected into Douglas Bags during the last minute of each stage and analysed for O</offsets><sub><offsets xml_i="16070" xml_f="16071" txt_i="8555" txt_f="8556">2</offsets></sub><offsets xml_i="16077" xml_f="16084" txt_i="8556" txt_f="8563"> and CO</offsets><sub><offsets xml_i="16089" xml_f="16090" txt_i="8563" txt_f="8564">2</offsets></sub><offsets xml_i="16096" xml_f="16223" txt_i="8564" txt_f="8691"> concentrations and volume. Following a five minute active rest period, an incremental “ramp” protocol was used to determine VO</offsets><sub><offsets xml_i="16228" xml_f="16232" txt_i="8691" txt_f="8695">2max</offsets></sub><offsets xml_i="16238" xml_f="16303" txt_i="8695" txt_f="8760">. Power began at 100 W and increased linearly with time (25 W.min</offsets><sup><offsets xml_i="16308" xml_f="16310" txt_i="8760" txt_f="8762">−1</offsets></sup><offsets xml_i="16316" xml_f="16447" txt_i="8762" txt_f="8893">). Participants cycled for as long as possible and verbal encouragement was given to elicit maximal effort. As the participant’s VO</offsets><sub><offsets xml_i="16452" xml_f="16456" txt_i="8893" txt_f="8897">2max</offsets></sub><offsets xml_i="16462" xml_f="16776" txt_i="8897" txt_f="9211"> was approached (as indicated by a change in breathing pattern), expired air was captured in Douglas bags until exhaustion. Analysis of Douglas bags was done using a calibrated gas analysing system (AD Instruments, Dunedin, New Zealand). The gas analyser was calibrated using gases of known concentration (15.01% O</offsets><sub><offsets xml_i="16781" xml_f="16782" txt_i="9211" txt_f="9212">2</offsets></sub><offsets xml_i="16788" xml_f="16798" txt_i="9212" txt_f="9222">, 5.01% CO</offsets><sub><offsets xml_i="16803" xml_f="16804" txt_i="9222" txt_f="9223">2</offsets></sub><offsets xml_i="16810" xml_f="16834" txt_i="9223" txt_f="9247">). Minute ventilation (V</offsets><sub><offsets xml_i="16839" xml_f="16840" txt_i="9247" txt_f="9248">E</offsets></sub><offsets xml_i="16846" xml_f="16871" txt_i="9248" txt_f="9273">) and concentrations of O</offsets><sub><offsets xml_i="16876" xml_f="16877" txt_i="9273" txt_f="9274">2</offsets></sub><offsets xml_i="16883" xml_f="16890" txt_i="9274" txt_f="9281"> and CO</offsets><sub><offsets xml_i="16895" xml_f="16896" txt_i="9281" txt_f="9282">2</offsets></sub><offsets xml_i="16902" xml_f="16962" txt_i="9282" txt_f="9342"> values were used to calculate the volume of inspired air (V</offsets><sub><offsets xml_i="16967" xml_f="16968" txt_i="9342" txt_f="9343">I</offsets></sub><offsets xml_i="16974" xml_f="17017" txt_i="9343" txt_f="9386">) using the Haldane transformation, where V</offsets><sub><offsets xml_i="17022" xml_f="17023" txt_i="9386" txt_f="9387">E</offsets></sub><offsets xml_i="17029" xml_f="17139" txt_i="9387" txt_f="9497"> was corrected for barometric pressure, ambient temperature and atmospheric water saturation. Subsequently, VO</offsets><sub><offsets xml_i="17144" xml_f="17145" txt_i="9497" txt_f="9498">2</offsets></sub><offsets xml_i="17151" xml_f="17166" txt_i="9498" txt_f="9513"> and expired CO</offsets><sub><offsets xml_i="17171" xml_f="17172" txt_i="9513" txt_f="9514">2</offsets></sub><offsets xml_i="17178" xml_f="17183" txt_i="9514" txt_f="9519"> (VCO</offsets><sub><offsets xml_i="17188" xml_f="17189" txt_i="9519" txt_f="9520">2</offsets></sub><offsets xml_i="17195" xml_f="17344" txt_i="9520" txt_f="9669">) could be determined and are reported as standard temperature and pressure dry (STPD). The respiratory exchange ratio (RER) was calculated using VCO</offsets><sub><offsets xml_i="17349" xml_f="17350" txt_i="9669" txt_f="9670">2</offsets></sub><offsets xml_i="17356" xml_f="17359" txt_i="9670" txt_f="9673">/VO</offsets><sub><offsets xml_i="17364" xml_f="17365" txt_i="9673" txt_f="9674">2</offsets></sub><offsets xml_i="17371" xml_f="17392" txt_i="9674" txt_f="9695"> and attainment of VO</offsets><sub><offsets xml_i="17397" xml_f="17401" txt_i="9695" txt_f="9699">2max</offsets></sub><offsets xml_i="17407" xml_f="17488" txt_i="9699" txt_f="9780"> was confirmed with RER ≥1.1. A relationship between steady-state workload and VO</offsets><sub><offsets xml_i="17493" xml_f="17494" txt_i="9780" txt_f="9781">2</offsets></sub><offsets xml_i="17500" xml_f="17726" txt_i="9781" txt_f="10007"> values was drawn through creation of a power curve and generation of a linear line equation y = mx + c, where m = gradient, x = power and c = start point. The equation was used to estimate power output at 50, 65 and 80% of VO</offsets><sub><offsets xml_i="17731" xml_f="17736" txt_i="10007" txt_f="10012">2max.</offsets></sub><offsets xml_i="17742" xml_f="17743" txt_i="10012" txt_f="10013">
</offsets></p></sec><sec id="Sec6"><title><offsets xml_i="17775" xml_f="17796" txt_i="10015" txt_f="10036">Experimental protocol</offsets></title><p><offsets xml_i="17807" xml_f="17839" txt_i="10037" txt_f="10069">The experimental protocol (Fig. </offsets><xref rid="Fig1" ref-type="fig"><offsets xml_i="17871" xml_f="17872" txt_i="10069" txt_f="10070">1</offsets></xref><offsets xml_i="17879" xml_f="18064" txt_i="10070" txt_f="10255">) was a randomized, double-blind, crossover design, which was completed on four occasions: twice in sea-level conditions (SEA) and twice in high-altitude conditions (ALT, 1657 m, ~17% O</offsets><sub><offsets xml_i="18069" xml_f="18070" txt_i="10255" txt_f="10256">2</offsets></sub><offsets xml_i="18076" xml_f="18516" txt_i="10256" txt_f="10696">). The testing location was the Turoa ski-field carpark, Ohakune, which was chosen due to being the highest road accessible to our mobile laboratory in the North Island of New Zealand. Prior to each trial, participants ingested 1000 mg of either a POMx supplement (POM Wonderful LLC, USA) in capsule form or a placebo capsule of the same colour, size and shape as POMx (PLAC, brown sugar). The quantity of POMx was based on Trexler et al. [</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="18548" xml_f="18549" txt_i="10696" txt_f="10697">7</offsets></xref><offsets xml_i="18556" xml_f="18827" txt_i="10697" txt_f="10968">] who showed an association between acute POMx supplementation and improved running performance. Previous analysis of the POM Wonderful LLC supplement have shown it to contain 1800 ppm polyphenols, comprised of 95.5% ellagitannins, 3.5% ellagic acid and 1% anthocyanins [</offsets><xref ref-type="bibr" rid="CR32"><offsets xml_i="18860" xml_f="18862" txt_i="10968" txt_f="10970">32</offsets></xref><offsets xml_i="18869" xml_f="19310" txt_i="10970" txt_f="11411">]. Participants completed a POMx trial and a PLAC trial in each environmental condition in a randomized order; the supplement blinded to the participant and the researcher. The participant was instructed to swallow the capsule whole, without tasting it, to avoid an expectation bias. In accordance with previous POMx research, the supplement was ingested 2.5 h prior to each experimental trial to allow maximal absorption prior to exercise [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="19342" xml_f="19343" txt_i="11411" txt_f="11412">9</offsets></xref><offsets xml_i="19350" xml_f="19442" txt_i="11412" txt_f="11504">]. During the 48 h prior to each session, participants were asked to limit consumption of NO</offsets><sub><offsets xml_i="19447" xml_f="19448" txt_i="11504" txt_f="11505">3</offsets></sub><offsets xml_i="19454" xml_f="19455" txt_i="11505" txt_f="11506">
</offsets><sup><offsets xml_i="19460" xml_f="19461" txt_i="11506" txt_f="11507">−</offsets></sup><offsets xml_i="19467" xml_f="19588" txt_i="11507" txt_f="11628"> and polyphenol-rich foods and avoid strenuous exercise and antibacterial substances, such as mouthwash, which destroy NO</offsets><sub><offsets xml_i="19593" xml_f="19594" txt_i="11628" txt_f="11629">3</offsets></sub><offsets xml_i="19600" xml_f="19601" txt_i="11629" txt_f="11630">
</offsets><sup><offsets xml_i="19606" xml_f="19607" txt_i="11630" txt_f="11631">−</offsets></sup><offsets xml_i="19613" xml_f="19617" txt_i="11631" txt_f="11635"> -NO</offsets><sub><offsets xml_i="19622" xml_f="19623" txt_i="11635" txt_f="11636">2</offsets></sub><offsets xml_i="19629" xml_f="19630" txt_i="11636" txt_f="11637">
</offsets><sup><offsets xml_i="19635" xml_f="19636" txt_i="11637" txt_f="11638">−</offsets></sup><offsets xml_i="19642" xml_f="19678" txt_i="11638" txt_f="11674"> converting bacteria on the tongue [</offsets><xref ref-type="bibr" rid="CR33"><offsets xml_i="19711" xml_f="19713" txt_i="11674" txt_f="11676">33</offsets></xref><offsets xml_i="19720" xml_f="19977" txt_i="11676" txt_f="11933">]. Participants consumed a standardized meal (524 cal, 8 g protein, 11 g fat, 51 g carbohydrate) three hours prior to exercise. Participants were asked to arrive at the testing session in a hydrated state, and consumed water ad libitum throughout the trial.</offsets><fig id="Fig1"><label><offsets xml_i="19999" xml_f="20005" txt_i="11933" txt_f="11939">Fig. 1</offsets></label><caption><p><offsets xml_i="20025" xml_f="20069" txt_i="11939" txt_f="11983">Schematic representation of the study design</offsets></p></caption><graphic xlink:href="12970_2017_172_Fig1_HTML" id="MO1"></graphic></fig><offsets xml_i="20155" xml_f="20156" txt_i="11984" txt_f="11985">
</offsets></p><p><offsets xml_i="20163" xml_f="20637" txt_i="11986" txt_f="12460">On arrival to the laboratory, body mass was obtained and a heart rate (HR) monitor (Garmin, Kansas, USA) was applied and recorded HR at a sampling rate of two seconds throughout the trial. After sitting in a supine position for five minutes, blood pressure of the brachial artery was measured using an automated sphygmomanometer (Japan Precision Instruments, Gumma, Japan). Blood was collected via fingerprick sample (~5 μL) and analysed for blood lactate concentration ([La</offsets><sup><offsets xml_i="20642" xml_f="20643" txt_i="12460" txt_f="12461">−</offsets></sup><offsets xml_i="20649" xml_f="20650" txt_i="12461" txt_f="12462">]</offsets><sub><offsets xml_i="20655" xml_f="20656" txt_i="12462" txt_f="12463">b</offsets></sub><offsets xml_i="20662" xml_f="21577" txt_i="12463" txt_f="13378">) using a blood lactate test meter (Lactate Pro, Arkray KDK, Japan). To determine haematocrit (Hct), additional blood (~35 μL) was collected from the fingertips in heparinized capillary microtubes and immediately spun in a microhaematocrit centifuge (Thermo IEC MB, Bellport, USA) at 14,000 rpm for two minutes. Hct was calculated as the length of red blood cells as a percentage of the total length of blood in the tube. Samples were taken in duplicate to allow calculation of an average value. In the SEA trials, a venous blood sample was also collected via venepuncture from the antecubital vein in heparinized vacutainers and immediately spun in a centrifuge (Eppendorf AG, Hamburg, Germany) at 2500 rpm for 12 min at 4 °C. Plasma was transferred into epindorphs and stored at −80 °C until analysis. The venous sample was not collected in ALT as samples could not be stored or analysed in the mobile laboratory.</offsets></p><p><offsets xml_i="21584" xml_f="21860" txt_i="13379" txt_f="13655">Following the pre-exercise measures, the participant mounted the ergometer to begin cycle exercise. The experimental protocol began with three x six minute stages of stationary cycling exercise at power outputs corresponding to 50, 65 and 80% of their previously determined VO</offsets><sub><offsets xml_i="21865" xml_f="21870" txt_i="13655" txt_f="13660">2max.</offsets></sub><offsets xml_i="21876" xml_f="21913" txt_i="13660" txt_f="13697"> In the last minute of each stage, VO</offsets><sub><offsets xml_i="21918" xml_f="21919" txt_i="13697" txt_f="13698">2</offsets></sub><offsets xml_i="21925" xml_f="22021" txt_i="13698" txt_f="13794"> was measured as previously described. Perceived exertion (RPE) was also recorded using Borg G [</offsets><xref ref-type="bibr" rid="CR34"><offsets xml_i="22054" xml_f="22056" txt_i="13794" txt_f="13796">34</offsets></xref><offsets xml_i="22063" xml_f="22207" txt_i="13796" txt_f="13940">] Scale of Perceived Exertion. Then, following a five minute rest, the load on the ergometer was increased to a workload calculated to elicit VO</offsets><sub><offsets xml_i="22212" xml_f="22216" txt_i="13940" txt_f="13944">2max</offsets></sub><offsets xml_i="22222" xml_f="22504" txt_i="13944" txt_f="14226"> and participants were instructed to ride at this intensity, at a cadence of ≥ 80 rpm for as long as possible, with the trial being terminated once the participant could not maintain the required cadence (for the previous 10 s) or at volitional exhaustion. Time to fatigue at 100%VO</offsets><sub><offsets xml_i="22509" xml_f="22513" txt_i="14226" txt_f="14230">2max</offsets></sub><offsets xml_i="22519" xml_f="22745" txt_i="14230" txt_f="14456"> (TTE100%) was chosen in this study as a performance measure rather than a self-paced time trial to enable physiological data to be collected and compared at the five minute point. Accordingly, five minutes into the TTE100% VO</offsets><sub><offsets xml_i="22750" xml_f="22751" txt_i="14456" txt_f="14457">2</offsets></sub><offsets xml_i="22757" xml_f="22771" txt_i="14457" txt_f="14471"> was measured.</offsets></p></sec></sec><sec id="Sec7"><title><offsets xml_i="22809" xml_f="22823" txt_i="14474" txt_f="14488">Blood analysis</offsets></title><p><offsets xml_i="22834" xml_f="22972" txt_i="14489" txt_f="14627">Plasma samples were analysed using a Nitric Oxide Colorimetric Assay Kit (BioVision Incorporated, Milpitas, California, USA) to measure NO</offsets><sub><offsets xml_i="22977" xml_f="22978" txt_i="14627" txt_f="14628">3</offsets></sub><offsets xml_i="22984" xml_f="22985" txt_i="14628" txt_f="14629">
</offsets><sup><offsets xml_i="22990" xml_f="22991" txt_i="14629" txt_f="14630">−</offsets></sup><offsets xml_i="22997" xml_f="23004" txt_i="14630" txt_f="14637"> and NO</offsets><sub><offsets xml_i="23009" xml_f="23010" txt_i="14637" txt_f="14638">2</offsets></sub><offsets xml_i="23016" xml_f="23017" txt_i="14638" txt_f="14639">
</offsets><sup><offsets xml_i="23022" xml_f="23023" txt_i="14639" txt_f="14640">−</offsets></sup><offsets xml_i="23029" xml_f="23114" txt_i="14640" txt_f="14725">. This method is a two-step process, in which nitrate reductase is used to convert NO</offsets><sub><offsets xml_i="23119" xml_f="23120" txt_i="14725" txt_f="14726">3</offsets></sub><offsets xml_i="23126" xml_f="23127" txt_i="14726" txt_f="14727">
</offsets><sup><offsets xml_i="23132" xml_f="23133" txt_i="14727" txt_f="14728">−</offsets></sup><offsets xml_i="23139" xml_f="23145" txt_i="14728" txt_f="14734"> to NO</offsets><sub><offsets xml_i="23150" xml_f="23151" txt_i="14734" txt_f="14735">2</offsets></sub><offsets xml_i="23157" xml_f="23158" txt_i="14735" txt_f="14736">
</offsets><sup><offsets xml_i="23163" xml_f="23164" txt_i="14736" txt_f="14737">−</offsets></sup><offsets xml_i="23170" xml_f="23207" txt_i="14737" txt_f="14774">, and then Greiss Reagents convert NO</offsets><sub><offsets xml_i="23212" xml_f="23213" txt_i="14774" txt_f="14775">2</offsets></sub><offsets xml_i="23219" xml_f="23220" txt_i="14775" txt_f="14776">
</offsets><sup><offsets xml_i="23225" xml_f="23226" txt_i="14776" txt_f="14777">−</offsets></sup><offsets xml_i="23232" xml_f="23324" txt_i="14777" txt_f="14869"> to a deep purple azo compound. Absorbance is read at 540 nm and plotted as a function of NO</offsets><sub><offsets xml_i="23329" xml_f="23330" txt_i="14869" txt_f="14870">3</offsets></sub><offsets xml_i="23336" xml_f="23337" txt_i="14870" txt_f="14871">
</offsets><sup><offsets xml_i="23342" xml_f="23343" txt_i="14871" txt_f="14872">−</offsets></sup><offsets xml_i="23349" xml_f="23356" txt_i="14872" txt_f="14879"> and NO</offsets><sub><offsets xml_i="23361" xml_f="23362" txt_i="14879" txt_f="14880">2</offsets></sub><offsets xml_i="23368" xml_f="23369" txt_i="14880" txt_f="14881">
</offsets><sup><offsets xml_i="23374" xml_f="23375" txt_i="14881" txt_f="14882">−</offsets></sup><offsets xml_i="23381" xml_f="23396" txt_i="14882" txt_f="14897"> concentration.</offsets></p></sec><sec id="Sec8"><title><offsets xml_i="23428" xml_f="23448" txt_i="14899" txt_f="14919">Statistical analyses</offsets></title><p><offsets xml_i="23459" xml_f="23941" txt_i="14920" txt_f="15402">Statistical analyses to compare the values of all variables measured were done using statistical computer software (SPSS Statistics, Version 23, IBM Corporation, New York). Normal distribution of data was confirmed with the Shapiro-Wilks test. Variables measured during the submaximal exercise stages were analysed using three-way repeated measures ANOVA to test the significance level for main effects of, and interactions between, altitude (SEA or ALT), workload (50, 65 and 80%VO</offsets><sub><offsets xml_i="23946" xml_f="23950" txt_i="15402" txt_f="15406">2max</offsets></sub><offsets xml_i="23956" xml_f="24146" txt_i="15406" txt_f="15596">) and treatment (PLAC or POMx). Similarly, two-way (altitude x treatment) repeated measures ANOVA was performed on all variables measured during the TTE100%. Where significant interactions (</offsets><italic><offsets xml_i="24154" xml_f="24155" txt_i="15596" txt_f="15597">p</offsets></italic><offsets xml_i="24164" xml_f="24426" txt_i="15597" txt_f="15859"> ≤ 0.05) were observed, two-tailed paired t-tests with a Fisher’s LSD post-hoc analysis were used to identify the location of the significance. The effect sizes (ES) of significant interactions were calculated using Cohen’s d (0.1 small; 0.5 medium; 0.8 large) [</offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="24459" xml_f="24461" txt_i="15859" txt_f="15861">35</offsets></xref><offsets xml_i="24468" xml_f="24498" txt_i="15861" txt_f="15891">]. The relationship between VO</offsets><sub><offsets xml_i="24503" xml_f="24504" txt_i="15891" txt_f="15892">2</offsets></sub><offsets xml_i="24510" xml_f="24675" txt_i="15892" txt_f="16057"> and performance during the TTE100% was analysed using the Pearson correlation coefficient. Data is presented as mean ± SD or mean change and 95% CI, as appropriate.</offsets></p></sec></sec><sec id="Sec9" sec-type="results"><title><offsets xml_i="24732" xml_f="24739" txt_i="16060" txt_f="16067">Results</offsets></title><p><offsets xml_i="24750" xml_f="24942" txt_i="16068" txt_f="16260">Participants’ self-reported adherence to supplement intake was 100% and no side effects of supplementation were reported. There was no order effect present for any of the significant results (</offsets><italic><offsets xml_i="24950" xml_f="24951" txt_i="16260" txt_f="16261">p</offsets></italic><offsets xml_i="24960" xml_f="24972" txt_i="16261" txt_f="16270"> &gt; 0.05).</offsets></p><sec id="Sec10"><title><offsets xml_i="24999" xml_f="25018" txt_i="16271" txt_f="16290">TTE100% performance</offsets></title><p><offsets xml_i="25029" xml_f="25231" txt_i="16291" txt_f="16493">Average performances during each condition were: SEAPLAC: 10.7 ± 2 min, SEAPOMx: 12.6 ± 8.7 min, ALTPLAC: 7.0 ± 2.3 min and ALTPOMx: 8.2 ± 4.5 min. There was no main effect of treatment on performance (</offsets><italic><offsets xml_i="25239" xml_f="25240" txt_i="16493" txt_f="16494">F</offsets></italic><offsets xml_i="25249" xml_f="25250" txt_i="16494" txt_f="16495">
</offsets><sub><offsets xml_i="25255" xml_f="25258" txt_i="16495" txt_f="16498">1,7</offsets></sub><offsets xml_i="25264" xml_f="25274" txt_i="16498" txt_f="16508"> = 0.776, </offsets><italic><offsets xml_i="25282" xml_f="25283" txt_i="16508" txt_f="16509">p</offsets></italic><offsets xml_i="25292" xml_f="25399" txt_i="16509" txt_f="16613"> &gt; 0.05). Performance was significantly decreased at ALT compared to SEA (−4.1 min, 95% CI, −6.9, −1.3, </offsets><italic><offsets xml_i="25407" xml_f="25408" txt_i="16613" txt_f="16614">F</offsets></italic><offsets xml_i="25417" xml_f="25418" txt_i="16614" txt_f="16615">
</offsets><sub><offsets xml_i="25423" xml_f="25426" txt_i="16615" txt_f="16618">1,7</offsets></sub><offsets xml_i="25432" xml_f="25441" txt_i="16618" txt_f="16627"> = 12.3, </offsets><italic><offsets xml_i="25449" xml_f="25450" txt_i="16627" txt_f="16628">p</offsets></italic><offsets xml_i="25459" xml_f="25579" txt_i="16628" txt_f="16745"> &lt; 0.02, ES = 0.8). The individual performance responses in the TTE100% to POMx in SEA and ALT are displayed in Fig. </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="25611" xml_f="25612" txt_i="16745" txt_f="16746">2</offsets></xref><offsets xml_i="25619" xml_f="25776" txt_i="16746" txt_f="16903">. Despite no overall significant effect of POMx, there appear to be two participants (HW and LS) who increased their performance with POMx in both altitudes.</offsets><fig id="Fig2"><label><offsets xml_i="25798" xml_f="25804" txt_i="16903" txt_f="16909">Fig. 2</offsets></label><caption><p><offsets xml_i="25824" xml_f="25877" txt_i="16909" txt_f="16962">Individual TTE100% performance responses to POMx in (</offsets><bold><offsets xml_i="25883" xml_f="25884" txt_i="16962" txt_f="16963">a</offsets></bold><offsets xml_i="25891" xml_f="25902" txt_i="16963" txt_f="16974">) SEA and (</offsets><bold><offsets xml_i="25908" xml_f="25909" txt_i="16974" txt_f="16975">b</offsets></bold><offsets xml_i="25916" xml_f="25921" txt_i="16975" txt_f="16980">) ALT</offsets></p></caption><graphic xlink:href="12970_2017_172_Fig2_HTML" id="MO2"></graphic></fig><offsets xml_i="26007" xml_f="26008" txt_i="16981" txt_f="16982">
</offsets></p></sec><sec id="Sec11"><title><offsets xml_i="26041" xml_f="26057" txt_i="16984" txt_f="17000">Resting measures</offsets></title><p><offsets xml_i="26068" xml_f="26077" txt_i="17001" txt_f="17010">Plasma NO</offsets><sub><offsets xml_i="26082" xml_f="26083" txt_i="17010" txt_f="17011">3</offsets></sub><offsets xml_i="26089" xml_f="26090" txt_i="17011" txt_f="17012">
</offsets><sup><offsets xml_i="26095" xml_f="26096" txt_i="17012" txt_f="17013">−</offsets></sup><offsets xml_i="26102" xml_f="26179" txt_i="17013" txt_f="17090"> was greater following POMx compared to PLAC (+10.3 μmol, 95% CI, 0.8, 19.7, </offsets><italic><offsets xml_i="26187" xml_f="26188" txt_i="17090" txt_f="17091">F</offsets></italic><offsets xml_i="26197" xml_f="26198" txt_i="17091" txt_f="17092">
</offsets><sub><offsets xml_i="26203" xml_f="26206" txt_i="17092" txt_f="17095">1,7</offsets></sub><offsets xml_i="26212" xml_f="26221" txt_i="17095" txt_f="17104"> = 7.83, </offsets><italic><offsets xml_i="26229" xml_f="26230" txt_i="17104" txt_f="17105">p</offsets></italic><offsets xml_i="26239" xml_f="26334" txt_i="17105" txt_f="17197"> &lt; 0.04, ES = 0.9). However, the assay used was not sensitive enough to detect changes in NO</offsets><sub><offsets xml_i="26339" xml_f="26340" txt_i="17197" txt_f="17198">2</offsets></sub><offsets xml_i="26346" xml_f="26347" txt_i="17198" txt_f="17199">
</offsets><sup><offsets xml_i="26352" xml_f="26353" txt_i="17199" txt_f="17200">−</offsets></sup><offsets xml_i="26359" xml_f="26412" txt_i="17200" txt_f="17253">. SBP was not significantly affected by POMx or ALT (</offsets><italic><offsets xml_i="26420" xml_f="26421" txt_i="17253" txt_f="17254">p</offsets></italic><offsets xml_i="26430" xml_f="26546" txt_i="17254" txt_f="17367"> &gt; 0.05). However, there was a trend towards an increase in SBP with POMx vs. PLAC (+3.9 bpm, 95% CI, −0.6, 8.5, </offsets><italic><offsets xml_i="26554" xml_f="26555" txt_i="17367" txt_f="17368">F</offsets></italic><offsets xml_i="26564" xml_f="26565" txt_i="17368" txt_f="17369">
</offsets><sub><offsets xml_i="26570" xml_f="26573" txt_i="17369" txt_f="17372">1,7</offsets></sub><offsets xml_i="26579" xml_f="26588" txt_i="17372" txt_f="17381"> = 4.28, </offsets><italic><offsets xml_i="26596" xml_f="26597" txt_i="17381" txt_f="17382">p</offsets></italic><offsets xml_i="26606" xml_f="26734" txt_i="17382" txt_f="17510"> = 0.08, ES = 0.3). There was a strong trend towards an increase in DBP with ALT, which showed a moderate effect size (+5 mmHg, </offsets><italic><offsets xml_i="26742" xml_f="26743" txt_i="17510" txt_f="17511">F</offsets></italic><offsets xml_i="26752" xml_f="26753" txt_i="17511" txt_f="17512">
</offsets><sub><offsets xml_i="26758" xml_f="26761" txt_i="17512" txt_f="17515">1,7</offsets></sub><offsets xml_i="26767" xml_f="26776" txt_i="17515" txt_f="17524"> = 1.18, </offsets><italic><offsets xml_i="26784" xml_f="26785" txt_i="17524" txt_f="17525">p</offsets></italic><offsets xml_i="26794" xml_f="26873" txt_i="17525" txt_f="17604"> = 0.054, ES = 0.6) and a significant treatment x altitude x time interaction (</offsets><italic><offsets xml_i="26881" xml_f="26882" txt_i="17604" txt_f="17605">F</offsets></italic><offsets xml_i="26891" xml_f="26892" txt_i="17605" txt_f="17606">
</offsets><sub><offsets xml_i="26897" xml_f="26900" txt_i="17606" txt_f="17609">1,7</offsets></sub><offsets xml_i="26906" xml_f="26915" txt_i="17609" txt_f="17618"> = 7.64, </offsets><italic><offsets xml_i="26923" xml_f="26924" txt_i="17618" txt_f="17619">p</offsets></italic><offsets xml_i="26933" xml_f="27084" txt_i="17619" txt_f="17767"> &lt; 0.03). However, post-hoc analyses revealed no significant differences between pre or post-exercise DBP with either treatment at either altitude (</offsets><italic><offsets xml_i="27092" xml_f="27093" txt_i="17767" txt_f="17768">p</offsets></italic><offsets xml_i="27102" xml_f="27178" txt_i="17768" txt_f="17841"> &gt; 0.05). Hct was significantly increased by ALT (+1.4%95% CI, 0.2, 2.6, </offsets><italic><offsets xml_i="27186" xml_f="27187" txt_i="17841" txt_f="17842">F</offsets></italic><offsets xml_i="27196" xml_f="27197" txt_i="17842" txt_f="17843">
</offsets><sub><offsets xml_i="27202" xml_f="27205" txt_i="17843" txt_f="17846">1,7</offsets></sub><offsets xml_i="27211" xml_f="27220" txt_i="17846" txt_f="17855"> = 7.56, </offsets><italic><offsets xml_i="27228" xml_f="27229" txt_i="17855" txt_f="17856">p</offsets></italic><offsets xml_i="27238" xml_f="27361" txt_i="17856" txt_f="17976"> &lt; 0.03, ES = 0.4) and significantly decreased by POMx, although the effect size was small (−0.76%, 95% CI, −1.3, −0.2, </offsets><italic><offsets xml_i="27369" xml_f="27370" txt_i="17976" txt_f="17977">F</offsets></italic><offsets xml_i="27379" xml_f="27380" txt_i="17977" txt_f="17978">
</offsets><sub><offsets xml_i="27385" xml_f="27388" txt_i="17978" txt_f="17981">1,7</offsets></sub><offsets xml_i="27394" xml_f="27403" txt_i="17981" txt_f="17990"> = 10.4, </offsets><italic><offsets xml_i="27411" xml_f="27412" txt_i="17990" txt_f="17991">p</offsets></italic><offsets xml_i="27421" xml_f="27443" txt_i="17991" txt_f="18010"> &lt; 0.02, ES = 0.2).</offsets></p></sec><sec id="Sec12"><title><offsets xml_i="27476" xml_f="27562" txt_i="18012" txt_f="18098">Pulmonary gas exchange, ventilatory and blood lactate responses to submaximal exercise</offsets></title><p><offsets xml_i="27573" xml_f="27676" txt_i="18099" txt_f="18202">There was no significant main effect of POMx nor any significant altitude x treatment interaction on VO</offsets><sub><offsets xml_i="27681" xml_f="27682" txt_i="18202" txt_f="18203">2</offsets></sub><offsets xml_i="27688" xml_f="27693" txt_i="18203" txt_f="18208">, VCO</offsets><sub><offsets xml_i="27698" xml_f="27699" txt_i="18208" txt_f="18209">2</offsets></sub><offsets xml_i="27705" xml_f="27716" txt_i="18209" txt_f="18220">, HR or [La</offsets><sup><offsets xml_i="27721" xml_f="27722" txt_i="18220" txt_f="18221">−</offsets></sup><offsets xml_i="27728" xml_f="27729" txt_i="18221" txt_f="18222">]</offsets><sub><offsets xml_i="27734" xml_f="27735" txt_i="18222" txt_f="18223">b</offsets></sub><offsets xml_i="27741" xml_f="27743" txt_i="18223" txt_f="18225"> (</offsets><italic><offsets xml_i="27751" xml_f="27752" txt_i="18225" txt_f="18226">p</offsets></italic><offsets xml_i="27761" xml_f="27892" txt_i="18226" txt_f="18354"> &gt; 0.5). There was a trend towards an increase in HR with POMx, but this had a small effect size (+2.3 bpm, 95% CI, −5.0, 0.5, F</offsets><sub><offsets xml_i="27897" xml_f="27900" txt_i="18354" txt_f="18357">1,7</offsets></sub><offsets xml_i="27906" xml_f="27915" txt_i="18357" txt_f="18366"> = 3.80, </offsets><italic><offsets xml_i="27923" xml_f="27924" txt_i="18366" txt_f="18367">p</offsets></italic><offsets xml_i="27933" xml_f="28007" txt_i="18367" txt_f="18441"> = 0.09, ES = 0.1). There was a significant main effect of altitude on [La</offsets><sup><offsets xml_i="28012" xml_f="28013" txt_i="18441" txt_f="18442">−</offsets></sup><offsets xml_i="28019" xml_f="28020" txt_i="18442" txt_f="18443">]</offsets><sub><offsets xml_i="28025" xml_f="28026" txt_i="18443" txt_f="18444">b</offsets></sub><offsets xml_i="28032" xml_f="28062" txt_i="18444" txt_f="18474"> (−0.8 μmol,95% CI, 0.3, 1.3, </offsets><italic><offsets xml_i="28070" xml_f="28071" txt_i="18474" txt_f="18475">F</offsets></italic><offsets xml_i="28080" xml_f="28081" txt_i="18475" txt_f="18476">
</offsets><sub><offsets xml_i="28086" xml_f="28089" txt_i="18476" txt_f="18479">1,7</offsets></sub><offsets xml_i="28095" xml_f="28104" txt_i="18479" txt_f="18488"> = 2.95, </offsets><italic><offsets xml_i="28112" xml_f="28113" txt_i="18488" txt_f="18489">p</offsets></italic><offsets xml_i="28122" xml_f="28144" txt_i="18489" txt_f="18508"> &lt; 0.01, ES = 0.6).</offsets></p></sec><sec id="Sec13"><title><offsets xml_i="28177" xml_f="28282" txt_i="18510" txt_f="18615">Pulmonary gas exchange, ventilatory and blood lactate responses to the time trial to exhaustion at 100%VO</offsets><sub><offsets xml_i="28287" xml_f="28291" txt_i="18615" txt_f="18619">2max</offsets></sub></title><p><offsets xml_i="28308" xml_f="28374" txt_i="18620" txt_f="18686">The variables measured during the TTE100% are summarized in Table </offsets><xref rid="Tab1" ref-type="table"><offsets xml_i="28408" xml_f="28409" txt_i="18686" txt_f="18687">1</offsets></xref><offsets xml_i="28416" xml_f="28549" txt_i="18687" txt_f="18820">. All data was recorded five minutes into the TTE100%. The two-way ANOVA showed a significant altitude x treatment interaction for VO</offsets><sub><offsets xml_i="28554" xml_f="28555" txt_i="18820" txt_f="18821">2</offsets></sub><offsets xml_i="28561" xml_f="28563" txt_i="18821" txt_f="18823"> (</offsets><italic><offsets xml_i="28571" xml_f="28572" txt_i="18823" txt_f="18824">F</offsets></italic><offsets xml_i="28581" xml_f="28582" txt_i="18824" txt_f="18825">
</offsets><sub><offsets xml_i="28587" xml_f="28590" txt_i="18825" txt_f="18828">1,7</offsets></sub><offsets xml_i="28596" xml_f="28605" txt_i="18828" txt_f="18837"> = 12.5, </offsets><italic><offsets xml_i="28613" xml_f="28614" txt_i="18837" txt_f="18838">p</offsets></italic><offsets xml_i="28623" xml_f="28698" txt_i="18838" txt_f="18913"> = 0.01). Post-hoc analysis identified that POMx significantly increased VO</offsets><sub><offsets xml_i="28703" xml_f="28704" txt_i="18913" txt_f="18914">2</offsets></sub><offsets xml_i="28710" xml_f="28730" txt_i="18914" txt_f="18934"> at ALT (+3.8 ml.min</offsets><sup><offsets xml_i="28735" xml_f="28737" txt_i="18934" txt_f="18936">−1</offsets></sup><offsets xml_i="28743" xml_f="28745" txt_i="18936" txt_f="18938">kg</offsets><sup><offsets xml_i="28750" xml_f="28752" txt_i="18938" txt_f="18940">−1</offsets></sup><offsets xml_i="28758" xml_f="28780" txt_i="18940" txt_f="18962">, 95% CI, −5.7, 9.5, F</offsets><sub><offsets xml_i="28785" xml_f="28788" txt_i="18962" txt_f="18965">1,7</offsets></sub><offsets xml_i="28794" xml_f="28803" txt_i="18965" txt_f="18974"> = 29.2, </offsets><italic><offsets xml_i="28811" xml_f="28812" txt_i="18974" txt_f="18975">p</offsets></italic><offsets xml_i="28821" xml_f="28848" txt_i="18975" txt_f="19002"> = 0.001) but not at SEA (F</offsets><sub><offsets xml_i="28853" xml_f="28856" txt_i="19002" txt_f="19005">1,7</offsets></sub><offsets xml_i="28862" xml_f="28871" txt_i="19005" txt_f="19014"> = 0.95, </offsets><italic><offsets xml_i="28879" xml_f="28880" txt_i="19014" txt_f="19015">p</offsets></italic><offsets xml_i="28889" xml_f="28995" txt_i="19015" txt_f="19118"> &gt; 0.05, ES = 0.2). Cohen’s d showed a moderate effect size of 0.6. There was no correlation between VO</offsets><sub><offsets xml_i="29000" xml_f="29001" txt_i="19118" txt_f="19119">2</offsets></sub><offsets xml_i="29007" xml_f="29040" txt_i="19119" txt_f="19152"> during the TTE and performance (</offsets><italic><offsets xml_i="29048" xml_f="29049" txt_i="19152" txt_f="19153">r</offsets></italic><offsets xml_i="29058" xml_f="29059" txt_i="19153" txt_f="19154">
</offsets><sup><offsets xml_i="29064" xml_f="29065" txt_i="19154" txt_f="19155">2</offsets></sup><offsets xml_i="29071" xml_f="29082" txt_i="19155" txt_f="19166"> = 0.0001, </offsets><italic><offsets xml_i="29090" xml_f="29091" txt_i="19166" txt_f="19167">p</offsets></italic><offsets xml_i="29100" xml_f="29174" txt_i="19167" txt_f="19241"> ≥ 0.05). There was a significant altitude x treatment interaction for VCO</offsets><sub><offsets xml_i="29179" xml_f="29180" txt_i="19241" txt_f="19242">2</offsets></sub><offsets xml_i="29186" xml_f="29189" txt_i="19242" txt_f="19245"> (F</offsets><sub><offsets xml_i="29194" xml_f="29197" txt_i="19245" txt_f="19248">1,7</offsets></sub><offsets xml_i="29203" xml_f="29212" txt_i="19248" txt_f="19257"> = 6.32, </offsets><italic><offsets xml_i="29220" xml_f="29221" txt_i="19257" txt_f="19258">p</offsets></italic><offsets xml_i="29230" xml_f="29338" txt_i="19258" txt_f="19363"> = &lt; 0.04). However, post-hoc analysis identified no significant differences between treatments at SEA (F</offsets><sub><offsets xml_i="29343" xml_f="29346" txt_i="19363" txt_f="19366">1,7</offsets></sub><offsets xml_i="29352" xml_f="29361" txt_i="19366" txt_f="19375"> = 1.76, </offsets><italic><offsets xml_i="29369" xml_f="29370" txt_i="19375" txt_f="19376">p</offsets></italic><offsets xml_i="29379" xml_f="29439" txt_i="19376" txt_f="19433"> &gt; 0.5, ES = 0.2), and a trend towards an increase in VCO</offsets><sub><offsets xml_i="29444" xml_f="29445" txt_i="19433" txt_f="19434">2</offsets></sub><offsets xml_i="29451" xml_f="29527" txt_i="19434" txt_f="19510"> with POMx at ALT with a moderate effect size (+3.6, 95% CI, −0.665, 7.82, F</offsets><sub><offsets xml_i="29532" xml_f="29535" txt_i="19510" txt_f="19513">1,7</offsets></sub><offsets xml_i="29541" xml_f="29550" txt_i="19513" txt_f="19522"> = 3.98, </offsets><italic><offsets xml_i="29558" xml_f="29559" txt_i="19522" txt_f="19523">p</offsets></italic><offsets xml_i="29568" xml_f="29598" txt_i="19523" txt_f="19553"> = 0.09, ES = 0.5). HR and [La</offsets><sup><offsets xml_i="29603" xml_f="29604" txt_i="19553" txt_f="19554">−</offsets></sup><offsets xml_i="29610" xml_f="29611" txt_i="19554" txt_f="19555">]</offsets><sub><offsets xml_i="29616" xml_f="29617" txt_i="19555" txt_f="19556">b</offsets></sub><offsets xml_i="29623" xml_f="29663" txt_i="19556" txt_f="19596"> were not affected by POMx or altitude (</offsets><italic><offsets xml_i="29671" xml_f="29672" txt_i="19596" txt_f="19597">p</offsets></italic><offsets xml_i="29681" xml_f="29692" txt_i="19597" txt_f="19605"> &gt; 0.5).</offsets><table-wrap id="Tab1"><label><offsets xml_i="29721" xml_f="29728" txt_i="19605" txt_f="19612">Table 1</offsets></label><caption><p><offsets xml_i="29748" xml_f="29785" txt_i="19612" txt_f="19649">Variables measured during the TTE100%</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th><offsets xml_i="29860" xml_f="29868" txt_i="19650" txt_f="19658">SEA-PLAC</offsets></th><th><offsets xml_i="29877" xml_f="29885" txt_i="19658" txt_f="19666">SEA-POMx</offsets></th><th><offsets xml_i="29894" xml_f="29902" txt_i="19666" txt_f="19674">ALT-PLAC</offsets></th><th><offsets xml_i="29911" xml_f="29919" txt_i="19674" txt_f="19682">ALT-POMx</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="29952" xml_f="29954" txt_i="19682" txt_f="19684">VO</offsets><sub><offsets xml_i="29959" xml_f="29960" txt_i="19684" txt_f="19685">2</offsets></sub><offsets xml_i="29966" xml_f="29977" txt_i="19685" txt_f="19696"> (ml.min.kg</offsets><sup><offsets xml_i="29982" xml_f="29984" txt_i="19696" txt_f="19698">−1</offsets></sup><offsets xml_i="29990" xml_f="29991" txt_i="19698" txt_f="19699">)</offsets></td><td char="±" align="char"></td><td char="±" align="char"><offsets xml_i="30053" xml_f="30063" txt_i="19701" txt_f="19711">68.5 ± 7.2</offsets></td><td char="±" align="char"><offsets xml_i="30094" xml_f="30104" txt_i="19712" txt_f="19722">63.2 ± 5.6</offsets><sup><offsets xml_i="30109" xml_f="30110" txt_i="19722" txt_f="19723">a</offsets></sup><offsets xml_i="30116" xml_f="30117" txt_i="19723" txt_f="19724">
</offsets></td><td char="±" align="char"><offsets xml_i="30148" xml_f="30158" txt_i="19725" txt_f="19735">66.9 ± 5.3</offsets><sup><offsets xml_i="30163" xml_f="30165" txt_i="19735" txt_f="19737">bc</offsets></sup><offsets xml_i="30171" xml_f="30172" txt_i="19737" txt_f="19738">
</offsets></td></tr><tr><td><offsets xml_i="30190" xml_f="30193" txt_i="19739" txt_f="19742">VCO</offsets><sub><offsets xml_i="30198" xml_f="30199" txt_i="19742" txt_f="19743">2</offsets></sub><offsets xml_i="30205" xml_f="30216" txt_i="19743" txt_f="19754"> (ml.min.kg</offsets><sup><offsets xml_i="30221" xml_f="30223" txt_i="19754" txt_f="19756">−1</offsets></sup><offsets xml_i="30229" xml_f="30230" txt_i="19756" txt_f="19757">)</offsets></td><td char="±" align="char"><offsets xml_i="30261" xml_f="30271" txt_i="19758" txt_f="19768">72.4 ± 7.8</offsets></td><td char="±" align="char"><offsets xml_i="30302" xml_f="30312" txt_i="19769" txt_f="19779">70.6 ± 8.9</offsets></td><td char="±" align="char"><offsets xml_i="30343" xml_f="30353" txt_i="19780" txt_f="19790">69.6 ± 7.1</offsets></td><td char="±" align="char"><offsets xml_i="30384" xml_f="30394" txt_i="19791" txt_f="19801">73.2 ± 8.0</offsets></td></tr><tr><td><offsets xml_i="30412" xml_f="30420" txt_i="19802" txt_f="19810">HR (bpm)</offsets></td><td char="±" align="char"><offsets xml_i="30451" xml_f="30458" txt_i="19811" txt_f="19818">186 ± 8</offsets></td><td char="±" align="char"><offsets xml_i="30489" xml_f="30496" txt_i="19819" txt_f="19826">175 ± 8</offsets></td><td char="±" align="char"><offsets xml_i="30527" xml_f="30534" txt_i="19827" txt_f="19834">184 ± 7</offsets></td><td char="±" align="char"><offsets xml_i="30565" xml_f="30572" txt_i="19835" txt_f="19842">184 ± 5</offsets></td></tr><tr><td><offsets xml_i="30590" xml_f="30593" txt_i="19843" txt_f="19846">[La</offsets><sup><offsets xml_i="30598" xml_f="30599" txt_i="19846" txt_f="19847">−</offsets></sup><offsets xml_i="30605" xml_f="30606" txt_i="19847" txt_f="19848">]</offsets><sub><offsets xml_i="30611" xml_f="30612" txt_i="19848" txt_f="19849">b</offsets></sub><offsets xml_i="30618" xml_f="30626" txt_i="19849" txt_f="19857"> (μmol.L</offsets><sup><offsets xml_i="30631" xml_f="30633" txt_i="19857" txt_f="19859">−1</offsets></sup><offsets xml_i="30639" xml_f="30640" txt_i="19859" txt_f="19860">)</offsets></td><td char="±" align="char"><offsets xml_i="30671" xml_f="30681" txt_i="19861" txt_f="19871">11.0 ± 3.7</offsets></td><td char="±" align="char"><offsets xml_i="30712" xml_f="30722" txt_i="19872" txt_f="19882">10.2 ± 2.9</offsets></td><td char="±" align="char"><offsets xml_i="30753" xml_f="30763" txt_i="19883" txt_f="19893">12.2 ± 3.9</offsets></td><td char="±" align="char"><offsets xml_i="30794" xml_f="30804" txt_i="19894" txt_f="19904">11.7 ± 3.9</offsets></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="30850" xml_f="30882" txt_i="19905" txt_f="19937">Data are presented as means ± SD</offsets></p><p><offsets xml_i="30889" xml_f="30890" txt_i="19938" txt_f="19939">
</offsets><italic><offsets xml_i="30898" xml_f="30900" txt_i="19939" txt_f="19941">VO</offsets></italic><offsets xml_i="30909" xml_f="30910" txt_i="19941" txt_f="19942">
</offsets><sub><italic><offsets xml_i="30923" xml_f="30924" txt_i="19942" txt_f="19943">2</offsets></italic></sub><offsets xml_i="30939" xml_f="30955" txt_i="19943" txt_f="19959"> oxygen uptake, </offsets><italic><offsets xml_i="30963" xml_f="30966" txt_i="19959" txt_f="19962">VCO</offsets></italic><offsets xml_i="30975" xml_f="30976" txt_i="19962" txt_f="19963">
</offsets><sub><italic><offsets xml_i="30989" xml_f="30990" txt_i="19963" txt_f="19964">2</offsets></italic></sub><offsets xml_i="31005" xml_f="31030" txt_i="19964" txt_f="19989"> expired carbon dioxide, </offsets><italic><offsets xml_i="31038" xml_f="31040" txt_i="19989" txt_f="19991">HR</offsets></italic><offsets xml_i="31049" xml_f="31062" txt_i="19991" txt_f="20004"> heart rate, </offsets><italic><offsets xml_i="31070" xml_f="31073" txt_i="20004" txt_f="20007">[La</offsets></italic><offsets xml_i="31082" xml_f="31083" txt_i="20007" txt_f="20008">
</offsets><sup><italic><offsets xml_i="31096" xml_f="31097" txt_i="20008" txt_f="20009">−</offsets></italic></sup><offsets xml_i="31112" xml_f="31113" txt_i="20009" txt_f="20010">
</offsets><italic><offsets xml_i="31121" xml_f="31122" txt_i="20010" txt_f="20011">]</offsets></italic><offsets xml_i="31131" xml_f="31132" txt_i="20011" txt_f="20012">
</offsets><sub><italic><offsets xml_i="31145" xml_f="31146" txt_i="20012" txt_f="20013">b</offsets></italic></sub><offsets xml_i="31161" xml_f="31191" txt_i="20013" txt_f="20043"> blood lactate concentration, </offsets><italic><offsets xml_i="31199" xml_f="31207" txt_i="20043" txt_f="20051">SEA-PLAC</offsets></italic><offsets xml_i="31216" xml_f="31236" txt_i="20051" txt_f="20071"> sea-level placebo, </offsets><italic><offsets xml_i="31244" xml_f="31252" txt_i="20071" txt_f="20079">SEA-POMx</offsets></italic><offsets xml_i="31261" xml_f="31293" txt_i="20079" txt_f="20111"> sea-level pomegranate extract, </offsets><italic><offsets xml_i="31301" xml_f="31309" txt_i="20111" txt_f="20119">ALT-PLAC</offsets></italic><offsets xml_i="31318" xml_f="31342" txt_i="20119" txt_f="20143"> high-altitude placebo, </offsets><italic><offsets xml_i="31350" xml_f="31358" txt_i="20143" txt_f="20151">ALT-POMx</offsets></italic><offsets xml_i="31367" xml_f="31401" txt_i="20151" txt_f="20185"> high-altitude pomegranate extract</offsets></p><p><offsets xml_i="31408" xml_f="31409" txt_i="20186" txt_f="20187">
</offsets><sup><offsets xml_i="31414" xml_f="31415" txt_i="20187" txt_f="20188">a</offsets></sup><offsets xml_i="31421" xml_f="31463" txt_i="20188" txt_f="20227">indicates P &lt; 0.05 compared to SEA-PLAC</offsets></p><p><offsets xml_i="31470" xml_f="31471" txt_i="20228" txt_f="20229">
</offsets><sup><offsets xml_i="31476" xml_f="31477" txt_i="20229" txt_f="20230">b</offsets></sup><offsets xml_i="31483" xml_f="31493" txt_i="20230" txt_f="20240">indicates </offsets><italic><offsets xml_i="31501" xml_f="31502" txt_i="20240" txt_f="20241">p</offsets></italic><offsets xml_i="31511" xml_f="31542" txt_i="20241" txt_f="20269"> &lt; 0.05 compared to SEA-POMx</offsets></p><p><offsets xml_i="31549" xml_f="31550" txt_i="20270" txt_f="20271">
</offsets><sup><offsets xml_i="31555" xml_f="31556" txt_i="20271" txt_f="20272">c</offsets></sup><offsets xml_i="31562" xml_f="31572" txt_i="20272" txt_f="20282">indicates </offsets><italic><offsets xml_i="31580" xml_f="31581" txt_i="20282" txt_f="20283">p</offsets></italic><offsets xml_i="31590" xml_f="31621" txt_i="20283" txt_f="20311"> &lt; 0.05 compared to ALT-PLAC</offsets></p></table-wrap-foot></table-wrap><offsets xml_i="31656" xml_f="31657" txt_i="20312" txt_f="20313">
</offsets></p></sec></sec><sec id="Sec14" sec-type="discussion"><title><offsets xml_i="31718" xml_f="31728" txt_i="20316" txt_f="20326">Discussion</offsets></title><p><offsets xml_i="31739" xml_f="31828" txt_i="20327" txt_f="20416">Although acute POMx supplementation was associated with a 10.3 μmol increase in plasma NO</offsets><sub><offsets xml_i="31833" xml_f="31834" txt_i="20416" txt_f="20417">3</offsets></sub><offsets xml_i="31840" xml_f="31841" txt_i="20417" txt_f="20418">
</offsets><sup><offsets xml_i="31846" xml_f="31847" txt_i="20418" txt_f="20419">−</offsets></sup><offsets xml_i="31853" xml_f="31874" txt_i="20419" txt_f="20440"> (95% CI, 0.8, 19.7, </offsets><italic><offsets xml_i="31882" xml_f="31883" txt_i="20440" txt_f="20441">p</offsets></italic><offsets xml_i="31892" xml_f="32073" txt_i="20441" txt_f="20619"> &lt; 0.04, ES = 0.9), its use as an acutely-ingested ergogenic supplement by highly-trained athletes is not supported by the current study, as neither performance nor submaximal VO</offsets><sub><offsets xml_i="32078" xml_f="32079" txt_i="20619" txt_f="20620">2</offsets></sub><offsets xml_i="32085" xml_f="32198" txt_i="20620" txt_f="20733"> were significantly altered by POMx ingestion. However, our data indicated that POMx does allow maintenance of VO</offsets><sub><offsets xml_i="32203" xml_f="32204" txt_i="20733" txt_f="20734">2</offsets></sub><offsets xml_i="32210" xml_f="32253" txt_i="20734" txt_f="20777"> at a workload prescribed to elicit 100% VO</offsets><sub><offsets xml_i="32258" xml_f="32262" txt_i="20777" txt_f="20781">2max</offsets></sub><offsets xml_i="32268" xml_f="32327" txt_i="20781" txt_f="20840"> (at sea level) during high intensity exercise under low PO</offsets><sub><offsets xml_i="32332" xml_f="32333" txt_i="20840" txt_f="20841">2</offsets></sub><offsets xml_i="32339" xml_f="32394" txt_i="20841" txt_f="20896"> conditions, despite no significant performance effect.</offsets></p><p><offsets xml_i="32401" xml_f="32495" txt_i="20897" txt_f="20991">The absence of changes in performance during the TTE100% is in agreement with Trinity et al. [</offsets><xref ref-type="bibr" rid="CR32"><offsets xml_i="32528" xml_f="32530" txt_i="20991" txt_f="20993">32</offsets></xref><offsets xml_i="32537" xml_f="32729" txt_i="20993" txt_f="21185">] who demonstrated no effect of acute POMJ supplementation on a cycling time trial or time to exhaustion protocol in hot conditions in moderately-trained individuals. However, Trexler et al. [</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="32761" xml_f="32762" txt_i="21185" txt_f="21186">7</offsets></xref><offsets xml_i="32769" xml_f="33103" txt_i="21186" txt_f="21520">] found an increase in time to exhaustion during treadmill running at 90–100% of peak velocity, in moderately trained participants, following acute supplementation of POMx (1000 mg, 30 min before exercise) at sea-level. In addition, POMx has been shown to improve performance and recovery from resistance and sprint cycling exercise [</offsets><xref ref-type="bibr" rid="CR36"><offsets xml_i="33136" xml_f="33138" txt_i="21520" txt_f="21522">36</offsets></xref><offsets xml_i="33145" xml_f="33147" txt_i="21522" txt_f="21524">, </offsets><xref ref-type="bibr" rid="CR37"><offsets xml_i="33180" xml_f="33182" txt_i="21524" txt_f="21526">37</offsets></xref><offsets xml_i="33189" xml_f="33486" txt_i="21526" txt_f="21823">]. The current study is the first study to test POMx supplementation in highly-trained endurance athletes and is in accordance with previous research involving acute BRJ supplementation in this cohort, which found no change in performance in a running or cycling time trial in hypoxic conditions [</offsets><xref ref-type="bibr" rid="CR28"><offsets xml_i="33519" xml_f="33521" txt_i="21823" txt_f="21825">28</offsets></xref><offsets xml_i="33528" xml_f="33530" txt_i="21825" txt_f="21827">, </offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="33563" xml_f="33565" txt_i="21827" txt_f="21829">29</offsets></xref><offsets xml_i="33572" xml_f="33629" txt_i="21829" txt_f="21886">]. However, two studies involving multi-day periods of NO</offsets><sub><offsets xml_i="33634" xml_f="33635" txt_i="21886" txt_f="21887">3</offsets></sub><offsets xml_i="33641" xml_f="33642" txt_i="21887" txt_f="21888">
</offsets><sup><offsets xml_i="33647" xml_f="33648" txt_i="21888" txt_f="21889">−</offsets></sup><offsets xml_i="33654" xml_f="33680" txt_i="21889" txt_f="21915"> supplementation in low PO</offsets><sub><offsets xml_i="33685" xml_f="33686" txt_i="21915" txt_f="21916">2</offsets></sub><offsets xml_i="33692" xml_f="33713" txt_i="21916" txt_f="21937"> conditions (11–13% O</offsets><sub><offsets xml_i="33718" xml_f="33719" txt_i="21937" txt_f="21938">2</offsets></sub><offsets xml_i="33725" xml_f="33751" txt_i="21938" txt_f="21964">) showed changes in both O</offsets><sub><offsets xml_i="33756" xml_f="33757" txt_i="21964" txt_f="21965">2</offsets></sub><offsets xml_i="33763" xml_f="33837" txt_i="21965" txt_f="22039"> parameters and exercise performance in moderately-trained individuals (VO</offsets><sub><offsets xml_i="33842" xml_f="33846" txt_i="22039" txt_f="22043">2max</offsets></sub><offsets xml_i="33852" xml_f="33865" txt_i="22043" txt_f="22056"> 58–61 ml.min</offsets><sup><offsets xml_i="33870" xml_f="33872" txt_i="22056" txt_f="22058">−1</offsets></sup><offsets xml_i="33878" xml_f="33880" txt_i="22058" txt_f="22060">kg</offsets><sup><offsets xml_i="33885" xml_f="33887" txt_i="22060" txt_f="22062">−1</offsets></sup><offsets xml_i="33893" xml_f="33910" txt_i="22062" txt_f="22079">). Kelly et al. [</offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="33943" xml_f="33945" txt_i="22079" txt_f="22081">31</offsets></xref><offsets xml_i="33952" xml_f="34013" txt_i="22081" txt_f="22142">] found that three days of BRJ supplementation (~8.4 mmol.day</offsets><sup><offsets xml_i="34018" xml_f="34020" txt_i="22142" txt_f="22144">−1</offsets></sup><offsets xml_i="34026" xml_f="34053" txt_i="22144" txt_f="22171">) decreased steady-state VO</offsets><sub><offsets xml_i="34058" xml_f="34059" txt_i="22171" txt_f="22172">2</offsets></sub><offsets xml_i="34065" xml_f="34305" txt_i="22172" txt_f="22412"> during a bout of moderate-intensity cycle exercise by 7.6% and this resulted in an 8% improvement in a subsequent high intensity time to exhaustion protocol, compared to exercise done following the intake of a placebo. Masschelein et al. [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="34338" xml_f="34340" txt_i="22412" txt_f="22414">30</offsets></xref><offsets xml_i="34347" xml_f="34404" txt_i="22414" txt_f="22471">] found that six days of BRJ supplementation (~5 mmol.day</offsets><sup><offsets xml_i="34409" xml_f="34411" txt_i="22471" txt_f="22473">−1</offsets></sup><offsets xml_i="34417" xml_f="34439" txt_i="22473" txt_f="22495">) increased arterial O</offsets><sub><offsets xml_i="34444" xml_f="34445" txt_i="22495" txt_f="22496">2</offsets></sub><offsets xml_i="34451" xml_f="34694" txt_i="22496" txt_f="22739"> saturation by 2.7% and the muscle tissue oxygenation index in the vastus lateralis by 4% during submaximal cycling. This resulted in a 5% increase in performance during a subsequent cycling graded exercise test. Thus, the small increase in VO</offsets><sub><offsets xml_i="34699" xml_f="34700" txt_i="22739" txt_f="22740">2</offsets></sub><offsets xml_i="34706" xml_f="34973" txt_i="22740" txt_f="23007"> with acute supplementation of POMx may not be sufficient to produce an ergogenic effect during a 100%TTE in highly-trained athletes and a longer period of supplementation may be necessary. Alternatively, the absence of change in performance despite an increase in VO</offsets><sub><offsets xml_i="34978" xml_f="34979" txt_i="23007" txt_f="23008">2</offsets></sub><offsets xml_i="34985" xml_f="35032" txt_i="23008" txt_f="23055"> may reflect the lack of correlation between VO</offsets><sub><offsets xml_i="35037" xml_f="35038" txt_i="23055" txt_f="23056">2</offsets></sub><offsets xml_i="35044" xml_f="35069" txt_i="23056" txt_f="23081"> and performance times (r</offsets><sup><offsets xml_i="35074" xml_f="35075" txt_i="23081" txt_f="23082">2</offsets></sup><offsets xml_i="35081" xml_f="35116" txt_i="23082" txt_f="23117"> = 0.0001), which indicates that VO</offsets><sub><offsets xml_i="35121" xml_f="35122" txt_i="23117" txt_f="23118">2</offsets></sub><offsets xml_i="35128" xml_f="35308" txt_i="23118" txt_f="23298"> was not the determining factor in the TTE100%. Rather, it is likely that other factors, such as anaerobic capacity, contribute more greatly to performance in a high-intensity TTE.</offsets></p><p><offsets xml_i="35315" xml_f="35401" txt_i="23299" txt_f="23385">To the authors’ knowledge, the current research is the first study to have measured VO</offsets><sub><offsets xml_i="35406" xml_f="35407" txt_i="23385" txt_f="23386">2</offsets></sub><offsets xml_i="35413" xml_f="35518" txt_i="23386" txt_f="23491"> during cycling exercise following supplementation with POMx. The lack of effect of POMx on submaximal VO</offsets><sub><offsets xml_i="35523" xml_f="35524" txt_i="23491" txt_f="23492">2</offsets></sub><offsets xml_i="35530" xml_f="35537" txt_i="23492" txt_f="23499"> or VCO</offsets><sub><offsets xml_i="35542" xml_f="35543" txt_i="23499" txt_f="23500">2</offsets></sub><offsets xml_i="35549" xml_f="35611" txt_i="23500" txt_f="23562"> values in either environment despite an increase in plasma NO</offsets><sub><offsets xml_i="35616" xml_f="35617" txt_i="23562" txt_f="23563">3</offsets></sub><offsets xml_i="35623" xml_f="35624" txt_i="23563" txt_f="23564">
</offsets><sup><offsets xml_i="35629" xml_f="35630" txt_i="23564" txt_f="23565">−</offsets></sup><offsets xml_i="35636" xml_f="35716" txt_i="23565" txt_f="23645"> is in accordance with previous research involving acute supplementation with NO</offsets><sub><offsets xml_i="35721" xml_f="35722" txt_i="23645" txt_f="23646">3</offsets></sub><offsets xml_i="35728" xml_f="35729" txt_i="23646" txt_f="23647">
</offsets><sup><offsets xml_i="35734" xml_f="35735" txt_i="23647" txt_f="23648">−</offsets></sup><offsets xml_i="35741" xml_f="35781" txt_i="23648" txt_f="23688">-rich BRJ in highly-trained athletes (VO</offsets><sub><offsets xml_i="35786" xml_f="35790" txt_i="23688" txt_f="23692">2max</offsets></sub><offsets xml_i="35796" xml_f="35807" txt_i="23692" txt_f="23700"> &gt;66 ml </offsets><sup><offsets xml_i="35812" xml_f="35814" txt_i="23700" txt_f="23702">−1</offsets></sup><offsets xml_i="35820" xml_f="35823" txt_i="23702" txt_f="23705">min</offsets><sup><offsets xml_i="35828" xml_f="35830" txt_i="23705" txt_f="23707">−1</offsets></sup><offsets xml_i="35836" xml_f="35838" txt_i="23707" txt_f="23709">kg</offsets><sup><offsets xml_i="35843" xml_f="35845" txt_i="23709" txt_f="23711">−1</offsets></sup><offsets xml_i="35851" xml_f="35877" txt_i="23711" txt_f="23737">) conducted at sea-level [</offsets><xref ref-type="bibr" rid="CR23"><offsets xml_i="35910" xml_f="35912" txt_i="23737" txt_f="23739">23</offsets></xref><offsets xml_i="35919" xml_f="35921" txt_i="23739" txt_f="23741">, </offsets><xref ref-type="bibr" rid="CR24"><offsets xml_i="35954" xml_f="35956" txt_i="23741" txt_f="23743">24</offsets></xref><offsets xml_i="35963" xml_f="35965" txt_i="23743" txt_f="23745">, </offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="35998" xml_f="36000" txt_i="23745" txt_f="23747">26</offsets></xref><offsets xml_i="36007" xml_f="36009" txt_i="23747" txt_f="23749">, </offsets><xref ref-type="bibr" rid="CR38"><offsets xml_i="36042" xml_f="36044" txt_i="23749" txt_f="23751">38</offsets></xref><offsets xml_i="36051" xml_f="36065" txt_i="23751" txt_f="23765">] or in low PO</offsets><sub><offsets xml_i="36070" xml_f="36071" txt_i="23765" txt_f="23766">2</offsets></sub><offsets xml_i="36077" xml_f="36098" txt_i="23766" txt_f="23787"> conditions (13–15% O</offsets><sub><offsets xml_i="36103" xml_f="36104" txt_i="23787" txt_f="23788">2</offsets></sub><offsets xml_i="36110" xml_f="36113" txt_i="23788" txt_f="23791">) [</offsets><xref ref-type="bibr" rid="CR28"><offsets xml_i="36146" xml_f="36148" txt_i="23791" txt_f="23793">28</offsets></xref><offsets xml_i="36155" xml_f="36157" txt_i="23793" txt_f="23795">, </offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="36190" xml_f="36192" txt_i="23795" txt_f="23797">29</offsets></xref><offsets xml_i="36199" xml_f="36242" txt_i="23797" txt_f="23840">]. In addition, the absence of change in VO</offsets><sub><offsets xml_i="36247" xml_f="36248" txt_i="23840" txt_f="23841">2</offsets></sub><offsets xml_i="36254" xml_f="36313" txt_i="23841" txt_f="23900"> during the TTE100% at SEA correlated with Boorsma et al. [</offsets><xref ref-type="bibr" rid="CR39"><offsets xml_i="36346" xml_f="36348" txt_i="23900" txt_f="23902">39</offsets></xref><offsets xml_i="36355" xml_f="36483" txt_i="23902" txt_f="24030">] who conducted a running protocol involving similar intensities to the current study, and found no significant difference in VO</offsets><sub><offsets xml_i="36488" xml_f="36489" txt_i="24030" txt_f="24031">2</offsets></sub><offsets xml_i="36495" xml_f="36571" txt_i="24031" txt_f="24107"> values during a 1500 m TT. The restoration of an ALT-induced lowering in VO</offsets><sub><offsets xml_i="36576" xml_f="36577" txt_i="24107" txt_f="24108">2</offsets></sub><offsets xml_i="36583" xml_f="36649" txt_i="24108" txt_f="24174"> during intense exercise following POMx compared to SEA (+3.8 Lmin</offsets><sup><offsets xml_i="36654" xml_f="36656" txt_i="24174" txt_f="24176">−1</offsets></sup><offsets xml_i="36662" xml_f="36683" txt_i="24176" txt_f="24197">, 95% CI, −5.7, 9.5, </offsets><italic><offsets xml_i="36691" xml_f="36692" txt_i="24197" txt_f="24198">p</offsets></italic><offsets xml_i="36701" xml_f="36746" txt_i="24198" txt_f="24243"> = 0.001, ES = 0.6) differed from previous NO</offsets><sub><offsets xml_i="36751" xml_f="36752" txt_i="24243" txt_f="24244">3</offsets></sub><offsets xml_i="36758" xml_f="36759" txt_i="24244" txt_f="24245">
</offsets><sup><offsets xml_i="36764" xml_f="36765" txt_i="24245" txt_f="24246">−</offsets></sup><offsets xml_i="36771" xml_f="36872" txt_i="24246" txt_f="24347">-based research involving highly-trained participants, although no other studies using hypoxia and VO</offsets><sub><offsets xml_i="36877" xml_f="36878" txt_i="24347" txt_f="24348">2</offsets></sub><offsets xml_i="36884" xml_f="36976" txt_i="24348" txt_f="24440"> measurement have utilised a performance test protocol similar to ours. Masschelein et al. [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="37009" xml_f="37011" txt_i="24440" txt_f="24442">30</offsets></xref><offsets xml_i="37018" xml_f="37041" txt_i="24442" txt_f="24465">] found no change in VO</offsets><sub><offsets xml_i="37046" xml_f="37050" txt_i="24465" txt_f="24469">2max</offsets></sub><offsets xml_i="37056" xml_f="37138" txt_i="24469" txt_f="24551"> recorded during a graded exercise test to exhaustion in hypoxic conditions (11% O</offsets><sub><offsets xml_i="37143" xml_f="37144" txt_i="24551" txt_f="24552">2</offsets></sub><offsets xml_i="37150" xml_f="37328" txt_i="24552" txt_f="24730">, ~5000 m altitude) despite a 4% increase in the muscle tissue oxygenation index. However, in that study, exercise intensity was not stable, as it was in the current study and VO</offsets><sub><offsets xml_i="37333" xml_f="37334" txt_i="24730" txt_f="24731">2</offsets></sub><offsets xml_i="37340" xml_f="37438" txt_i="24731" txt_f="24829"> was measured at exhaustion, rather than part-way into the exercise. In addition, MacLeod et al. [</offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="37471" xml_f="37473" txt_i="24829" txt_f="24831">29</offsets></xref><offsets xml_i="37480" xml_f="37506" txt_i="24831" txt_f="24857">] recorded no change in VO</offsets><sub><offsets xml_i="37511" xml_f="37512" txt_i="24857" txt_f="24858">2</offsets></sub><offsets xml_i="37518" xml_f="37735" txt_i="24858" txt_f="25075"> during a 10 km cycling time trial completed in a normobaric hypoxic chamber (~2440 m altitude). However, the duration of this test was significantly longer than ours, which may have influenced potential effects on VO</offsets><sub><offsets xml_i="37740" xml_f="37741" txt_i="25075" txt_f="25076">2</offsets></sub><offsets xml_i="37747" xml_f="37748" txt_i="25076" txt_f="25077">.</offsets></p><p><offsets xml_i="37755" xml_f="37772" txt_i="25078" txt_f="25095">The changes in VO</offsets><sub><offsets xml_i="37777" xml_f="37778" txt_i="25095" txt_f="25096">2</offsets></sub><offsets xml_i="37784" xml_f="37887" txt_i="25096" txt_f="25199"> in the current study were likely driven by the high polyphenol content of POMx, as POMx has a lower NO</offsets><sub><offsets xml_i="37892" xml_f="37893" txt_i="25199" txt_f="25200">3</offsets></sub><offsets xml_i="37899" xml_f="37900" txt_i="25200" txt_f="25201">
</offsets><sup><offsets xml_i="37905" xml_f="37906" txt_i="25201" txt_f="25202">−</offsets></sup><offsets xml_i="37912" xml_f="38024" txt_i="25202" txt_f="25314"> concentration than BRJ. While BRJ-based research in highly-trained athletes has recorded increases in plasma NO</offsets><sub><offsets xml_i="38029" xml_f="38030" txt_i="25314" txt_f="25315">3</offsets></sub><offsets xml_i="38036" xml_f="38037" txt_i="25315" txt_f="25316">
</offsets><sup><offsets xml_i="38042" xml_f="38043" txt_i="25316" txt_f="25317">−</offsets></sup><offsets xml_i="38049" xml_f="38063" txt_i="25317" txt_f="25331"> of 31–1907% [</offsets><xref ref-type="bibr" rid="CR27"><offsets xml_i="38096" xml_f="38098" txt_i="25331" txt_f="25333">27</offsets></xref><offsets xml_i="38105" xml_f="38107" txt_i="25333" txt_f="25335">, </offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="38140" xml_f="38142" txt_i="25335" txt_f="25337">31</offsets></xref><offsets xml_i="38149" xml_f="38151" txt_i="25337" txt_f="25339">, </offsets><xref ref-type="bibr" rid="CR39"><offsets xml_i="38184" xml_f="38186" txt_i="25339" txt_f="25341">39</offsets></xref><offsets xml_i="38193" xml_f="38243" txt_i="25341" txt_f="25391">], the current study measured a 44% increase in NO</offsets><sub><offsets xml_i="38248" xml_f="38249" txt_i="25391" txt_f="25392">3</offsets></sub><offsets xml_i="38255" xml_f="38256" txt_i="25392" txt_f="25393">
</offsets><sup><offsets xml_i="38261" xml_f="38262" txt_i="25393" txt_f="25394">−</offsets></sup><offsets xml_i="38268" xml_f="38438" txt_i="25394" txt_f="25564"> with POMx. Although polyphenolic compounds are also present in BRJ, these are predominantly from the quercetin subclass, in comparison to the high ET component in POMx [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="38471" xml_f="38473" txt_i="25564" txt_f="25566">40</offsets></xref><offsets xml_i="38480" xml_f="38572" txt_i="25566" txt_f="25658">]. Previous research has generally found no link between quercetin intake, and changes in VO</offsets><sub><offsets xml_i="38577" xml_f="38578" txt_i="25658" txt_f="25659">2</offsets></sub><offsets xml_i="38584" xml_f="38612" txt_i="25659" txt_f="25687"> or performance parameters [</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="38645" xml_f="38647" txt_i="25687" txt_f="25689">41</offsets></xref><offsets xml_i="38654" xml_f="38656" txt_i="25689" txt_f="25691">, </offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="38689" xml_f="38691" txt_i="25691" txt_f="25693">42</offsets></xref><offsets xml_i="38698" xml_f="38870" txt_i="25693" txt_f="25865">]. However an increase in pre or post-exercise blood flow and vessel diameter has been observed with consumption of ET or anthocyanin-containing fruit juices and extracts [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="38902" xml_f="38903" txt_i="25865" txt_f="25866">6</offsets></xref><offsets xml_i="38910" xml_f="38912" txt_i="25866" txt_f="25868">, </offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="38944" xml_f="38945" txt_i="25868" txt_f="25869">7</offsets></xref><offsets xml_i="38952" xml_f="38954" txt_i="25869" txt_f="25871">, </offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="38987" xml_f="38989" txt_i="25871" txt_f="25873">11</offsets></xref><offsets xml_i="38996" xml_f="39024" txt_i="25873" txt_f="25901">]. Further, Ignarro et al. [</offsets><xref ref-type="bibr" rid="CR17"><offsets xml_i="39057" xml_f="39059" txt_i="25901" txt_f="25903">17</offsets></xref><offsets xml_i="39066" xml_f="39277" txt_i="25903" txt_f="26114">] demonstrated that POMJ is more effective at protecting NO from breakdown than other polyphenol-containing juices and red wine, with significant antioxidant actions occurring at dilutions greater than 1000-fold</offsets><italic><offsets xml_i="39285" xml_f="39286" txt_i="26114" txt_f="26115">.</offsets></italic><offsets xml_i="39295" xml_f="39318" txt_i="26115" txt_f="26138"> Thus, the increased VO</offsets><sub><offsets xml_i="39323" xml_f="39324" txt_i="26138" txt_f="26139">2</offsets></sub><offsets xml_i="39330" xml_f="39443" txt_i="26139" txt_f="26252"> during the TTE100% following POMx supplementation may be due to a polyphenol-induced greater NO bioavailability.</offsets></p><p><offsets xml_i="39450" xml_f="39574" txt_i="26253" txt_f="26377">Despite the large amount of research indicating a relationship between a supplement-induced increase in NO and changes in VO</offsets><sub><offsets xml_i="39579" xml_f="39580" txt_i="26377" txt_f="26378">2</offsets></sub><offsets xml_i="39586" xml_f="39657" txt_i="26378" txt_f="26449"> during exercise, presumably through an increase in the efficiency of O</offsets><sub><offsets xml_i="39662" xml_f="39663" txt_i="26449" txt_f="26450">2</offsets></sub><offsets xml_i="39669" xml_f="39861" txt_i="26450" txt_f="26642"> transport, the mechanisms behind these changes are currently irresolute. Although NO is known to mediate vasoactivity, an overall increase in vasodilation does not explain the reduction in VO</offsets><sub><offsets xml_i="39866" xml_f="39867" txt_i="26642" txt_f="26643">2</offsets></sub><offsets xml_i="39873" xml_f="39955" txt_i="26643" txt_f="26725"> during submaximal exercise in normoxia which has been observed in other studies [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="39988" xml_f="39990" txt_i="26725" txt_f="26727">18</offsets></xref><offsets xml_i="39997" xml_f="39998" txt_i="26727" txt_f="26728">–</offsets><xref ref-type="bibr" rid="CR22"><offsets xml_i="40031" xml_f="40033" txt_i="26728" txt_f="26730">22</offsets></xref><offsets xml_i="40040" xml_f="40122" txt_i="26730" txt_f="26812">]. Rather, the predominant mechanistic theories to explain the effects of NO on VO</offsets><sub><offsets xml_i="40127" xml_f="40128" txt_i="26812" txt_f="26813">2</offsets></sub><offsets xml_i="40134" xml_f="40198" txt_i="26813" txt_f="26877"> involve an increase in either the efficiency of mitochondrial O</offsets><sub><offsets xml_i="40203" xml_f="40204" txt_i="26877" txt_f="26878">2</offsets></sub><offsets xml_i="40210" xml_f="40268" txt_i="26878" txt_f="26936"> usage or in the muscular use of ATP, affording a lower VO</offsets><sub><offsets xml_i="40273" xml_f="40274" txt_i="26936" txt_f="26937">2</offsets></sub><offsets xml_i="40280" xml_f="40323" txt_i="26937" txt_f="26980"> requirement to sustain a given work rate [</offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="40356" xml_f="40358" txt_i="26980" txt_f="26982">21</offsets></xref><offsets xml_i="40365" xml_f="40367" txt_i="26982" txt_f="26984">, </offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="40400" xml_f="40402" txt_i="26984" txt_f="26986">43</offsets></xref><offsets xml_i="40409" xml_f="40585" txt_i="26986" txt_f="27162">]. However, during exercise under hypoxic conditions, a NO-induced augmentation in vasodilation has been shown to be important in maintaining blood flow to the active muscles [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="40618" xml_f="40620" txt_i="27162" txt_f="27164">44</offsets></xref><offsets xml_i="40627" xml_f="40749" txt_i="27164" txt_f="27286">]. Thus, it is likely that under hypoxic conditions, the vasoactive role of NO contributes more greatly to the level of VO</offsets><sub><offsets xml_i="40754" xml_f="40755" txt_i="27286" txt_f="27287">2</offsets></sub><offsets xml_i="40761" xml_f="40847" txt_i="27287" txt_f="27373"> which can be achieved during intense exercise. In accordance with previous research [</offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="40880" xml_f="40882" txt_i="27373" txt_f="27375">26</offsets></xref><offsets xml_i="40889" xml_f="40891" txt_i="27375" txt_f="27377">, </offsets><xref ref-type="bibr" rid="CR28"><offsets xml_i="40924" xml_f="40926" txt_i="27377" txt_f="27379">28</offsets></xref><offsets xml_i="40933" xml_f="40959" txt_i="27379" txt_f="27405">], POMx did not affect [La</offsets><sup><offsets xml_i="40964" xml_f="40965" txt_i="27405" txt_f="27406">−</offsets></sup><offsets xml_i="40971" xml_f="40972" txt_i="27406" txt_f="27407">]</offsets><sub><offsets xml_i="40977" xml_f="40978" txt_i="27407" txt_f="27408">b</offsets></sub><offsets xml_i="40984" xml_f="41071" txt_i="27408" txt_f="27495">, indicating that any changes observed were probably not due to a change in fuel usage.</offsets></p><p><offsets xml_i="41078" xml_f="41141" txt_i="27496" txt_f="27559">Several reasons have been proposed for the lower efficacy of NO</offsets><sub><offsets xml_i="41146" xml_f="41147" txt_i="27559" txt_f="27560">3</offsets></sub><offsets xml_i="41153" xml_f="41154" txt_i="27560" txt_f="27561">
</offsets><sup><offsets xml_i="41159" xml_f="41160" txt_i="27561" txt_f="27562">−</offsets></sup><offsets xml_i="41166" xml_f="41199" txt_i="27562" txt_f="27595"> supplementation on submaximal VO</offsets><sub><offsets xml_i="41204" xml_f="41205" txt_i="27595" txt_f="27596">2</offsets></sub><offsets xml_i="41211" xml_f="41355" txt_i="27596" txt_f="27740"> and performance in trained compared to untrained individuals. Firstly, as a response to training, athletes tend to have elevated NOS activity [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="41388" xml_f="41390" txt_i="27740" txt_f="27742">45</offsets></xref><offsets xml_i="41397" xml_f="41421" txt_i="27742" txt_f="27766">], and higher resting NO</offsets><sub><offsets xml_i="41426" xml_f="41427" txt_i="27766" txt_f="27767">2</offsets></sub><offsets xml_i="41433" xml_f="41434" txt_i="27767" txt_f="27768">
</offsets><sup><offsets xml_i="41439" xml_f="41440" txt_i="27768" txt_f="27769">−</offsets></sup><offsets xml_i="41446" xml_f="41453" txt_i="27769" txt_f="27776"> and NO</offsets><sub><offsets xml_i="41458" xml_f="41459" txt_i="27776" txt_f="27777">3</offsets></sub><offsets xml_i="41465" xml_f="41466" txt_i="27777" txt_f="27778">
</offsets><sup><offsets xml_i="41471" xml_f="41472" txt_i="27778" txt_f="27779">−</offsets></sup><offsets xml_i="41478" xml_f="41487" txt_i="27779" txt_f="27788"> values [</offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="41520" xml_f="41522" txt_i="27788" txt_f="27790">46</offsets></xref><offsets xml_i="41529" xml_f="41586" txt_i="27790" txt_f="27847">]. Consequently, they may have a lower requirement for NO</offsets><sub><offsets xml_i="41591" xml_f="41592" txt_i="27847" txt_f="27848">3</offsets></sub><offsets xml_i="41598" xml_f="41599" txt_i="27848" txt_f="27849">
</offsets><sup><offsets xml_i="41604" xml_f="41605" txt_i="27849" txt_f="27850">−</offsets></sup><offsets xml_i="41611" xml_f="41614" txt_i="27850" txt_f="27853">-NO</offsets><sub><offsets xml_i="41619" xml_f="41620" txt_i="27853" txt_f="27854">2</offsets></sub><offsets xml_i="41626" xml_f="41627" txt_i="27854" txt_f="27855">
</offsets><sup><offsets xml_i="41632" xml_f="41633" txt_i="27855" txt_f="27856">−</offsets></sup><offsets xml_i="41639" xml_f="41674" txt_i="27856" txt_f="27891">-NO pathway, and have sufficient NO</offsets><sub><offsets xml_i="41679" xml_f="41680" txt_i="27891" txt_f="27892">3</offsets></sub><offsets xml_i="41686" xml_f="41687" txt_i="27892" txt_f="27893">
</offsets><sup><offsets xml_i="41692" xml_f="41693" txt_i="27893" txt_f="27894">−</offsets></sup><offsets xml_i="41699" xml_f="41788" txt_i="27894" txt_f="27983"> present in the blood to use it when needed. Further, training adaptations which aid in O</offsets><sub><offsets xml_i="41793" xml_f="41794" txt_i="27983" txt_f="27984">2</offsets></sub><offsets xml_i="41800" xml_f="42025" txt_i="27984" txt_f="28209"> transport and energy production, such as increased capillarization and mitochondrial density, may reduce the incidence of acidic and hypoxic muscular environments, which decrease NOS activity, and increase reliance on the NO</offsets><sub><offsets xml_i="42030" xml_f="42031" txt_i="28209" txt_f="28210">3</offsets></sub><offsets xml_i="42037" xml_f="42038" txt_i="28210" txt_f="28211">
</offsets><sup><offsets xml_i="42043" xml_f="42044" txt_i="28211" txt_f="28212">−</offsets></sup><offsets xml_i="42050" xml_f="42060" txt_i="28212" txt_f="28222"> pathway [</offsets><xref ref-type="bibr" rid="CR25"><offsets xml_i="42093" xml_f="42095" txt_i="28222" txt_f="28224">25</offsets></xref><offsets xml_i="42102" xml_f="42104" txt_i="28224" txt_f="28226">, </offsets><xref ref-type="bibr" rid="CR47"><offsets xml_i="42137" xml_f="42139" txt_i="28226" txt_f="28228">47</offsets></xref><offsets xml_i="42146" xml_f="42200" txt_i="28228" txt_f="28282">]. Finally, research in rats has suggested that the NO</offsets><sub><offsets xml_i="42205" xml_f="42206" txt_i="28282" txt_f="28283">3</offsets></sub><offsets xml_i="42212" xml_f="42213" txt_i="28283" txt_f="28284">
</offsets><sup><offsets xml_i="42218" xml_f="42219" txt_i="28284" txt_f="28285">−</offsets></sup><offsets xml_i="42225" xml_f="42345" txt_i="28285" txt_f="28405"> pathway is predominantly used in type II muscle fibres, which work more frequently under acidic or hypoxic conditions [</offsets><xref ref-type="bibr" rid="CR48"><offsets xml_i="42378" xml_f="42380" txt_i="28405" txt_f="28407">48</offsets></xref><offsets xml_i="42387" xml_f="42413" txt_i="28407" txt_f="28433">]. If this is the case, NO</offsets><sub><offsets xml_i="42418" xml_f="42419" txt_i="28433" txt_f="28434">3</offsets></sub><offsets xml_i="42425" xml_f="42426" txt_i="28434" txt_f="28435">
</offsets><sup><offsets xml_i="42431" xml_f="42432" txt_i="28435" txt_f="28436">−</offsets></sup><offsets xml_i="42438" xml_f="42559" txt_i="28436" txt_f="28557"> supplementation may be more effective in untrained individuals who tend to have a greater percentage of type II fibres [</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="42592" xml_f="42594" txt_i="28557" txt_f="28559">49</offsets></xref><offsets xml_i="42601" xml_f="43140" txt_i="28559" txt_f="29098">]. However, currently, there is no direct evidence that type II fibres are preferentially affected in humans. Alternatively, the lack of overall performance response may be due to the presence of ‘responders’ and ‘non-responders’ to POMx. Despite no overall significant effect of POMx on performance in the current study, there were two participants who increased performance in both altitudes. Thus, a larger sample size of participants may be needed to determine the ratio of responders vs. non-responders in a highly-trained population.</offsets></p><p><offsets xml_i="43147" xml_f="43459" txt_i="29099" txt_f="29411">In addition to the results already presented in the discussion, the current study produced two results which are difficult to explain. Firstly, in contrast to previous research which has reported a lowering in SBP following acute BRJ or ET polyphenols from grapes in sedentary or moderately-trained individuals [</offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="43492" xml_f="43494" txt_i="29411" txt_f="29413">11</offsets></xref><offsets xml_i="43501" xml_f="43503" txt_i="29413" txt_f="29415">, </offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="43536" xml_f="43538" txt_i="29415" txt_f="29417">18</offsets></xref><offsets xml_i="43545" xml_f="43547" txt_i="29417" txt_f="29419">, </offsets><xref ref-type="bibr" rid="CR50"><offsets xml_i="43580" xml_f="43582" txt_i="29419" txt_f="29421">50</offsets></xref><offsets xml_i="43589" xml_f="43674" txt_i="29421" txt_f="29506">], and no effect on SBP following BRJ supplementation in highly-trained individuals [</offsets><xref ref-type="bibr" rid="CR25"><offsets xml_i="43707" xml_f="43709" txt_i="29506" txt_f="29508">25</offsets></xref><offsets xml_i="43716" xml_f="43718" txt_i="29508" txt_f="29510">, </offsets><xref ref-type="bibr" rid="CR27"><offsets xml_i="43751" xml_f="43753" txt_i="29510" txt_f="29512">27</offsets></xref><offsets xml_i="43760" xml_f="43762" txt_i="29512" txt_f="29514">, </offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="43795" xml_f="43797" txt_i="29514" txt_f="29516">29</offsets></xref><offsets xml_i="43804" xml_f="43806" txt_i="29516" txt_f="29518">, </offsets><xref ref-type="bibr" rid="CR38"><offsets xml_i="43839" xml_f="43841" txt_i="29518" txt_f="29520">38</offsets></xref><offsets xml_i="43848" xml_f="43943" txt_i="29520" txt_f="29615">], this study found a trend towards an increase in SBP with POMx (+3.9 bpm, 95% CI, −0.6, 8.5, </offsets><italic><offsets xml_i="43951" xml_f="43952" txt_i="29615" txt_f="29616">p</offsets></italic><offsets xml_i="43961" xml_f="44478" txt_i="29616" txt_f="30133"> = 0.08). The only explanation we can give for this result is that the increase in SBP was a reactive response by the vasculatare to ensure that the mean arterial pressure and thus, vessel perfusion and blood flow, were maintained, despite the NO-induced vasodilation. Further, being an acute intervention, we did not anticipate changes in Hct with POMx, but surprisingly, there was a significant decrease in Hct following POMx compared to PLAC (−0.76%, 95% CI, −1.3, −0.2), which indicated a small reduction in the O</offsets><sub><offsets xml_i="44483" xml_f="44484" txt_i="30133" txt_f="30134">2</offsets></sub><offsets xml_i="44490" xml_f="44640" txt_i="30134" txt_f="30284">-carrying capacity of the blood. However, despite being significant, this change had a small effect size (ES = 0.2) and considering the increase in VO</offsets><sub><offsets xml_i="44645" xml_f="44646" txt_i="30284" txt_f="30285">2</offsets></sub><offsets xml_i="44652" xml_f="44698" txt_i="30285" txt_f="30331"> with POMx at ALT, did not appear to affect VO</offsets><sub><offsets xml_i="44703" xml_f="44704" txt_i="30331" txt_f="30332">2</offsets></sub><offsets xml_i="44710" xml_f="44756" txt_i="30332" txt_f="30378"> capacity. Hct varies from day to day by ~3% [</offsets><xref ref-type="bibr" rid="CR51"><offsets xml_i="44789" xml_f="44791" txt_i="30378" txt_f="30380">51</offsets></xref><offsets xml_i="44798" xml_f="45170" txt_i="30380" txt_f="30752">] and it is possible that this result was due to differences in hydration between tests, as we did not measure pre-exercise hydration status, or standardize water intake during exercise. However both these explanations are purely speculative and further research is required to determine whether POMx supplementation consistently results in similar effects on SBP and Hct.</offsets></p><p><offsets xml_i="45177" xml_f="45360" txt_i="30753" txt_f="30936">A limitation to the current study is the relatively low altitude used in the hypoxic condition compared to the altitude generally associated with physiological changes (2500–3000 m) [</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="45393" xml_f="45395" txt_i="30936" txt_f="30938">52</offsets></xref><offsets xml_i="45402" xml_f="45455" txt_i="30938" txt_f="30991">] and that simulated in previous studies involving NO</offsets><sub><offsets xml_i="45460" xml_f="45461" txt_i="30991" txt_f="30992">3</offsets></sub><offsets xml_i="45467" xml_f="45468" txt_i="30992" txt_f="30993">
</offsets><sup><offsets xml_i="45473" xml_f="45474" txt_i="30993" txt_f="30994">−</offsets></sup><offsets xml_i="45480" xml_f="45524" txt_i="30994" txt_f="31038"> supplementation in hypoxia (~2500–5000 m) [</offsets><xref ref-type="bibr" rid="CR28"><offsets xml_i="45557" xml_f="45559" txt_i="31038" txt_f="31040">28</offsets></xref><offsets xml_i="45566" xml_f="45568" txt_i="31040" txt_f="31042">, </offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="45601" xml_f="45603" txt_i="31042" txt_f="31044">30</offsets></xref><offsets xml_i="45610" xml_f="45612" txt_i="31044" txt_f="31046">, </offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="45645" xml_f="45647" txt_i="31046" txt_f="31048">31</offsets></xref><offsets xml_i="45654" xml_f="46075" txt_i="31048" txt_f="31466">]. Due to our study being conducted in a mobile laboratory, we were restricted to areas with vehicle access in the North Island of New Zealand, and conducted the study at the highest altitude possible under these conditions. However, future studies could investigate the potential ergogenic benefit of POMx at a higher altitude of &gt;2500 m. In addition, the current study was limited by a relatively small sample size (</offsets><italic><offsets xml_i="46083" xml_f="46084" txt_i="31466" txt_f="31467">n</offsets></italic><offsets xml_i="46093" xml_f="46261" txt_i="31467" txt_f="31635"> = 8), which was unavoidable due to the research taking place during a high-performance junior training camp. While previous research has demonstrated a reduction in VO</offsets><sub><offsets xml_i="46266" xml_f="46267" txt_i="31635" txt_f="31636">2</offsets></sub><offsets xml_i="46273" xml_f="46310" txt_i="31636" txt_f="31673"> during submaximal cycling exercise [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="46343" xml_f="46345" txt_i="31673" txt_f="31675">18</offsets></xref><offsets xml_i="46352" xml_f="46354" txt_i="31675" txt_f="31677">, </offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="46387" xml_f="46389" txt_i="31677" txt_f="31679">21</offsets></xref><offsets xml_i="46396" xml_f="46466" txt_i="31679" txt_f="31749">], it is acknowledged that the lack of effect of POMx on submaximal VO</offsets><sub><offsets xml_i="46471" xml_f="46472" txt_i="31749" txt_f="31750">2</offsets></sub><offsets xml_i="46478" xml_f="46560" txt_i="31750" txt_f="31832"> in the current study may have been due to an insufficient number of participants.</offsets></p></sec><sec id="Sec15" sec-type="conclusion"><title><offsets xml_i="46615" xml_f="46625" txt_i="31834" txt_f="31844">Conclusion</offsets></title><p><offsets xml_i="46636" xml_f="46713" txt_i="31845" txt_f="31922">In conclusion, acute POMx supplementation allowed a partial restoration of VO</offsets><sub><offsets xml_i="46718" xml_f="46719" txt_i="31922" txt_f="31923">2</offsets></sub><offsets xml_i="46725" xml_f="46813" txt_i="31923" txt_f="32011"> during intense exercise in a hypoxic environment. However, no significant changes in VO</offsets><sub><offsets xml_i="46818" xml_f="46819" txt_i="32011" txt_f="32012">2</offsets></sub><offsets xml_i="46825" xml_f="47060" txt_i="32012" txt_f="32247"> occurred during submaximal exercise and there was no effect of POMx on performance in either environment. Thus, the results from the current study do not support POMx as an ergogenic supplement when ingested acutely prior to exercise.</offsets></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>[La<sup>−</sup>]<sub>b</sub></term><def><p>Plasma lactate concentration</p></def></def-item><def-item><term>ALT</term><def><p>High altitude conditions</p></def></def-item><def-item><term>BRJ</term><def><p>Beetroot juice</p></def></def-item><def-item><term>CO<sub>2</sub></term><def><p>Carbon dioxide</p></def></def-item><def-item><term>DBP</term><def><p>Diastolic blood pressure</p></def></def-item><def-item><term>ET</term><def><p>Ellagitannin polyphenols</p></def></def-item><def-item><term>Hct</term><def><p>Haematocrit</p></def></def-item><def-item><term>HR</term><def><p>Heart rate</p></def></def-item><def-item><term>NO</term><def><p>Nitric oxide</p></def></def-item><def-item><term>NO<sub>2</sub><sup>−</sup></term><def><p>Nitrites</p></def></def-item><def-item><term>NO<sub>3</sub><sup>−</sup></term><def><p>Nitrates</p></def></def-item><def-item><term>NOS</term><def><p>Nitric oxide synthases</p></def></def-item><def-item><term>O<sub>2</sub></term><def><p>Oxygen</p></def></def-item><def-item><term>PLAC</term><def><p>Placebo</p></def></def-item><def-item><term>POM</term><def><p>Pomegranate</p></def></def-item><def-item><term>POMJ</term><def><p>Pomegranate juice</p></def></def-item><def-item><term>POMx</term><def><p>Pomegranate extract</p></def></def-item><def-item><term>RER</term><def><p>Respiratory exchange ratio</p></def></def-item><def-item><term>ROS</term><def><p>Reactive oxygen species</p></def></def-item><def-item><term>RPE</term><def><p>Rating of perceived exertion</p></def></def-item><def-item><term>SBP</term><def><p>Systolic blood pressure</p></def></def-item><def-item><term>SEA</term><def><p>Sea level conditions</p></def></def-item><def-item><term>TTE100%</term><def><p>Time trial to exhaustion at 100%VO<sub>2max</sub>
</p></def></def-item><def-item><term>VCO<sub>2</sub></term><def><p>Volume of expired carbon dioxide</p></def></def-item><def-item><term>V<sub>E</sub></term><def><p>Volume of expired air</p></def></def-item><def-item><term>V<sub>I</sub></term><def><p>Volume of inspired air</p></def></def-item><def-item><term>VO<sub>2</sub></term><def><p>Volume of oxygen consumption</p></def></def-item><def-item><term>VO<sub>2max</sub></term><def><p>Maximal oxygen consumption</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>We thank the cyclists from the local cycling community who took part in the study, and the Massey University Institute of Food Science and Technology, who performed the blood analysis.</p><sec id="FPar1"><title>Funding</title><p>This investigation was supported by a Massey University Doctoral scholarship.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p>The datasets used and analysed during the current study are available from the corresponding author on reasonable request.</p></sec><sec id="FPar3"><title>Authors’ contributions</title><p>The study was designed by EC and SS; data were collected and analysed by EC, AM and SS, data interpretation and manuscript preparation were undertaken by EC with the assistance of SS and MB. All authors read and approved the final version of the paper.</p></sec><sec id="FPar4"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar5"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar6"><title>Ethics approval and consent to participate</title><p>The participants were notified of all the potential risks and benefits associated with the study before written consent was obtained. The study was approved by the Massey University Human Ethics Committee (Southern A 15/54) in accordance with the Declaration of Helsinki, and written and verbal consent was obtained prior to commencement of the study.</p></sec><sec id="FPar7"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname><given-names>T</given-names></name><name><surname>Sestili</surname><given-names>P</given-names></name><name><surname>Akhtar</surname><given-names>S</given-names></name></person-group><article-title>Pomegranate peel and fruit extracts. a review of potential anti-inflammatory and anti-infective effects</article-title><source>J Ethnopharmacol</source><year>2012</year><volume>143</volume><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2012.07.004</pub-id><pub-id pub-id-type="pmid">22820239</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>LS</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Seeram</surname><given-names>NP</given-names></name><name><surname>Heber</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name></person-group><article-title>Pomegranate ellagitannin–derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro</article-title><source>Cancer Prev Res</source><year>2010</year><volume>3</volume><fpage>108</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-08-0225</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aviram</surname><given-names>M</given-names></name><name><surname>Rosenblat</surname><given-names>M</given-names></name><name><surname>Gaitini</surname><given-names>D</given-names></name><name><surname>Nitecki</surname><given-names>S</given-names></name><name><surname>Hoffman</surname><given-names>A</given-names></name><name><surname>Dornfeld</surname><given-names>L</given-names></name><name><surname>Volkova</surname><given-names>N</given-names></name><name><surname>Presser</surname><given-names>D</given-names></name><name><surname>Attias</surname><given-names>J</given-names></name><name><surname>Liker</surname><given-names>H</given-names></name></person-group><article-title>Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation</article-title><source>Clin Nutr</source><year>2004</year><volume>23</volume><fpage>423</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2003.10.002</pub-id><pub-id pub-id-type="pmid">15158307</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name><name><surname>Rasheed</surname><given-names>Z</given-names></name><name><surname>Khan</surname><given-names>KA</given-names></name><name><surname>Haqqi</surname><given-names>TM</given-names></name></person-group><article-title>Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis</article-title><source>Nutrition</source><year>2008</year><volume>24</volume><fpage>733</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2008.03.013</pub-id><pub-id pub-id-type="pmid">18490140</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sergent</surname><given-names>T</given-names></name><name><surname>Piront</surname><given-names>N</given-names></name><name><surname>Meurice</surname><given-names>J</given-names></name><name><surname>Toussaint</surname><given-names>O</given-names></name><name><surname>Schneider</surname><given-names>Y-J</given-names></name></person-group><article-title>Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium</article-title><source>Chem Biol Interact</source><year>2010</year><volume>188</volume><fpage>659</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2010.08.007</pub-id><pub-id pub-id-type="pmid">20816778</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roelofs</surname><given-names>EJ</given-names></name><name><surname>Smith-Ryan</surname><given-names>AE</given-names></name><name><surname>Trexler</surname><given-names>ET</given-names></name><name><surname>Hirsch</surname><given-names>KR</given-names></name><name><surname>Mock</surname><given-names>MG</given-names></name></person-group><article-title>Effects of pomegranate extract on blood flow and vessel diameter after high-intensity exercise in young, healthy adults</article-title><source>Eur J Sport Sci</source><year>2016</year><volume>17</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">27800713</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trexler</surname><given-names>ET</given-names></name><name><surname>Smith-Ryan</surname><given-names>AE</given-names></name><name><surname>Melvin</surname><given-names>MN</given-names></name><name><surname>Roelofs</surname><given-names>EJ</given-names></name><name><surname>Wingfield</surname><given-names>HL</given-names></name></person-group><article-title>The effects of pomegranate extract on blood flow and running time to exhaustion</article-title><source>Appl Physiol Nutr Metab</source><year>2014</year><volume>39</volume><fpage>1038</fpage><pub-id pub-id-type="doi">10.1139/apnm-2014-0137</pub-id><pub-id pub-id-type="pmid">25051173</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>L</given-names></name></person-group><article-title>Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance</article-title><source>Nutr Rev</source><year>1998</year><volume>56</volume><fpage>317</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.1998.tb01670.x</pub-id><pub-id pub-id-type="pmid">9838798</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeram</surname><given-names>NP</given-names></name><name><surname>Aviram</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Henning</surname><given-names>SM</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Dreher</surname><given-names>M</given-names></name><name><surname>Heber</surname><given-names>D</given-names></name></person-group><article-title>Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States</article-title><source>J Agri Food Chem</source><year>2008</year><volume>56</volume><fpage>1415</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1021/jf073035s</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeram</surname><given-names>NP</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Heber</surname><given-names>D</given-names></name></person-group><article-title>Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice</article-title><source>Clin Chim Acta</source><year>2004</year><volume>348</volume><fpage>63</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.cccn.2004.04.029</pub-id><pub-id pub-id-type="pmid">15369737</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barona</surname><given-names>J</given-names></name><name><surname>Aristizabal</surname><given-names>JC</given-names></name><name><surname>Blesso</surname><given-names>CN</given-names></name><name><surname>Volek</surname><given-names>JS</given-names></name><name><surname>Fernandez</surname><given-names>ML</given-names></name></person-group><article-title>Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome</article-title><source>J Nutr</source><year>2012</year><volume>142</volume><fpage>1626</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.3945/jn.112.162743</pub-id><pub-id pub-id-type="pmid">22810991</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labonté</surname><given-names>K</given-names></name><name><surname>Couillard</surname><given-names>C</given-names></name><name><surname>Motard-Bélanger</surname><given-names>A</given-names></name><name><surname>Paradis</surname><given-names>M-E</given-names></name><name><surname>Couture</surname><given-names>P</given-names></name><name><surname>Lamarche</surname><given-names>B</given-names></name></person-group><article-title>Acute effects of polyphenols from cranberries and grape seeds on endothelial function and performance in elite athletes</article-title><source>Sports</source><year>2013</year><volume>1</volume><fpage>55</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.3390/sports1030055</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moncada</surname><given-names>S</given-names></name><name><surname>Higgs</surname><given-names>A</given-names></name></person-group><article-title>The L-arginine-nitric oxide pathway</article-title><source>N Engl J Med</source><year>1993</year><volume>329</volume><fpage></fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1056/NEJM199312303292706</pub-id><pub-id pub-id-type="pmid">7504210</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundberg</surname><given-names>J</given-names></name><name><surname>Weitzberg</surname><given-names>E</given-names></name><name><surname>Lundberg</surname><given-names>J</given-names></name><name><surname>Alving</surname><given-names>K</given-names></name></person-group><article-title>Intragastric nitric oxide production in humans: measurements in expelled air</article-title><source>Gut</source><year>1994</year><volume>35</volume><fpage>1543</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1136/gut.35.11.1543</pub-id><pub-id pub-id-type="pmid">7828969</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peri</surname><given-names>L</given-names></name><name><surname>Pietraforte</surname><given-names>D</given-names></name><name><surname>Scorza</surname><given-names>G</given-names></name><name><surname>Napolitano</surname><given-names>A</given-names></name><name><surname>Fogliano</surname><given-names>V</given-names></name><name><surname>Minetti</surname><given-names>M</given-names></name></person-group><article-title>Apples increase nitric oxide production by human saliva at the acidic pH of the stomach: a new biological function for polyphenols with a catechol group?</article-title><source>Free Radic Biol Med</source><year>2005</year><volume>39</volume><fpage>668</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2005.04.021</pub-id><pub-id pub-id-type="pmid">16085185</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gago</surname><given-names>B</given-names></name><name><surname>Lundberg</surname><given-names>JO</given-names></name><name><surname>Barbosa</surname><given-names>RM</given-names></name><name><surname>Laranjinha</surname><given-names>J</given-names></name></person-group><article-title>Red wine-dependent reduction of nitrite to nitric oxide in the stomach</article-title><source>Free Radic Biol Med</source><year>2007</year><volume>43</volume><fpage>1233</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.06.007</pub-id><pub-id pub-id-type="pmid">17893036</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ignarro</surname><given-names>LJ</given-names></name><name><surname>Byrns</surname><given-names>RE</given-names></name><name><surname>Sumi</surname><given-names>D</given-names></name><name><surname>de Nigris</surname><given-names>F</given-names></name><name><surname>Napoli</surname><given-names>C</given-names></name></person-group><article-title>Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide</article-title><source>Nitric Oxide</source><year>2006</year><volume>15</volume><fpage>93</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2006.03.001</pub-id><pub-id pub-id-type="pmid">16626982</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>SJ</given-names></name><name><surname>Winyard</surname><given-names>P</given-names></name><name><surname>Vanhatalo</surname><given-names>A</given-names></name><name><surname>Blackwell</surname><given-names>JR</given-names></name><name><surname>DiMenna</surname><given-names>FJ</given-names></name><name><surname>Wilkerson</surname><given-names>DP</given-names></name><name><surname>Tarr</surname><given-names>J</given-names></name><name><surname>Benjamin</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name></person-group><article-title>Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans</article-title><source>J Appl Physiol</source><year>2009</year><volume>107</volume><fpage>1144</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00722.2009</pub-id><pub-id pub-id-type="pmid">19661447</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wylie</surname><given-names>LJ</given-names></name><name><surname>Kelly</surname><given-names>J</given-names></name><name><surname>Bailey</surname><given-names>SJ</given-names></name><name><surname>Blackwell</surname><given-names>JR</given-names></name><name><surname>Skiba</surname><given-names>PF</given-names></name><name><surname>Winyard</surname><given-names>PG</given-names></name><name><surname>Jeukendrup</surname><given-names>AE</given-names></name><name><surname>Vanhatalo</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name></person-group><article-title>Beetroot juice and exercise: pharmacodynamic and dose-response relationships</article-title><source>J Appl Physiol</source><year>2013</year><volume>115</volume><fpage>325</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00372.2013</pub-id><pub-id pub-id-type="pmid">23640589</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breese</surname><given-names>BC</given-names></name><name><surname>McNarry</surname><given-names>MA</given-names></name><name><surname>Marwood</surname><given-names>S</given-names></name><name><surname>Blackwell</surname><given-names>JR</given-names></name><name><surname>Bailey</surname><given-names>SJ</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name></person-group><article-title>Beetroot juice supplementation speeds O2 uptake kinetics and improves exercise tolerance during severe-intensity exercise initiated from an elevated metabolic rate</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2013</year><volume>305</volume><fpage>R1441</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00295.2013</pub-id><pub-id pub-id-type="pmid">24089377</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>SJ</given-names></name><name><surname>Fulford</surname><given-names>J</given-names></name><name><surname>Vanhatalo</surname><given-names>A</given-names></name><name><surname>Winyard</surname><given-names>PG</given-names></name><name><surname>Blackwell</surname><given-names>JR</given-names></name><name><surname>DiMenna</surname><given-names>FJ</given-names></name><name><surname>Wilkerson</surname><given-names>DP</given-names></name><name><surname>Benjamin</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name></person-group><article-title>Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans</article-title><source>J Appl Physiol</source><year>2010</year><volume>109</volume><fpage>135</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00046.2010</pub-id><pub-id pub-id-type="pmid">20466802</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lansley</surname><given-names>KE</given-names></name><name><surname>Winyard</surname><given-names>PG</given-names></name><name><surname>Fulford</surname><given-names>J</given-names></name><name><surname>Vanhatalo</surname><given-names>A</given-names></name><name><surname>Bailey</surname><given-names>SJ</given-names></name><name><surname>Blackwell</surname><given-names>JR</given-names></name><name><surname>DiMenna</surname><given-names>FJ</given-names></name><name><surname>Gilchrist</surname><given-names>M</given-names></name><name><surname>Benjamin</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name></person-group><article-title>Dietary nitrate supplementation reduces the O2 cost of walking and running: a placebo-controlled study</article-title><source>J Appl Physiol</source><year>2011</year><volume>110</volume><fpage>591</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01070.2010</pub-id><pub-id pub-id-type="pmid">21071588</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porcelli</surname><given-names>S</given-names></name><name><surname>Ramaglia</surname><given-names>M</given-names></name><name><surname>Bellistri</surname><given-names>G</given-names></name><name><surname>Pavei</surname><given-names>G</given-names></name><name><surname>Pugliese</surname><given-names>L</given-names></name><name><surname>Montorsi</surname><given-names>M</given-names></name><name><surname>Rasica</surname><given-names>L</given-names></name><name><surname>Marzorati</surname><given-names>M</given-names></name></person-group><article-title>Aerobic fitness affects the exercise performance responses to nitrate supplementation</article-title><source>Med Sci Sports Exerc</source><year>2015</year><volume>47</volume><fpage>1643</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1249/MSS.0000000000000577</pub-id><pub-id pub-id-type="pmid">25412295</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peacock</surname><given-names>O</given-names></name><name><surname>Tjonna</surname><given-names>AE</given-names></name><name><surname>James</surname><given-names>P</given-names></name><name><surname>Wisloff</surname><given-names>U</given-names></name><name><surname>Welde</surname><given-names>B</given-names></name><name><surname>Bohlke</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Stokes</surname><given-names>K</given-names></name><name><surname>Cook</surname><given-names>C</given-names></name><name><surname>Sandbakk</surname><given-names>O</given-names></name></person-group><article-title>Dietary nitrate does not enhance running performance in elite cross-country skiers</article-title><source>Med Sci Sports Exerc</source><year>2012</year><volume>44</volume><fpage>2213</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3182640f48</pub-id><pub-id pub-id-type="pmid">22874535</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkerson</surname><given-names>DP</given-names></name><name><surname>Hayward</surname><given-names>GM</given-names></name><name><surname>Bailey</surname><given-names>SJ</given-names></name><name><surname>Vanhatalo</surname><given-names>A</given-names></name><name><surname>Blackwell</surname><given-names>JR</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name></person-group><article-title>Influence of acute dietary nitrate supplementation on 50 mile time trial performance in well-trained cyclists</article-title><source>Eur J Appl Physiol</source><year>2012</year><volume>112</volume><fpage>4127</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1007/s00421-012-2397-6</pub-id><pub-id pub-id-type="pmid">22526247</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bescós</surname><given-names>R</given-names></name><name><surname>Rodríguez</surname><given-names>FA</given-names></name><name><surname>Iglesias</surname><given-names>X</given-names></name><name><surname>Ferrer</surname><given-names>MD</given-names></name><name><surname>Iborra</surname><given-names>E</given-names></name><name><surname>Pons</surname><given-names>A</given-names></name></person-group><article-title>Acute administration of inorganic nitrate reduces VO2peak in endurance athletes</article-title><source>Med Sci Sports Exerc</source><year>2011</year><volume>43</volume><fpage>1979</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e318217d439</pub-id><pub-id pub-id-type="pmid">21407132</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cermak</surname><given-names>NM</given-names></name><name><surname>Gibala</surname><given-names>MJ</given-names></name><name><surname>van Loon</surname><given-names>LJ</given-names></name></person-group><article-title>Nitrate supplementation’s improvement of 10-km time-trial performance in trained cyclists</article-title><source>Int J Sport Nutr Exerc Metab</source><year>2012</year><volume>22</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.22.1.64</pub-id><pub-id pub-id-type="pmid">22248502</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>JT</given-names></name><name><surname>Oliver</surname><given-names>SJ</given-names></name><name><surname>Lewis-Jones</surname><given-names>TM</given-names></name><name><surname>Wylie</surname><given-names>LJ</given-names></name><name><surname>Macdonald</surname><given-names>JH</given-names></name></person-group><article-title>Beetroot juice does not enhance altitude running performance in well-trained athletes</article-title><source>Appl Physiol Nutr Metab</source><year>2015</year><volume>40</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1139/apnm-2014-0470</pub-id><pub-id pub-id-type="pmid">25494678</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLeod</surname><given-names>K</given-names></name><name><surname>Nugent</surname><given-names>S</given-names></name><name><surname>Barr</surname><given-names>S</given-names></name><name><surname>Koehle</surname><given-names>M</given-names></name><name><surname>Sporer</surname><given-names>B</given-names></name><name><surname>MacInnis</surname><given-names>M</given-names></name></person-group><article-title>Acute beetroot juice supplementation does not improve cycling performance in normoxia or moderate hypoxia</article-title><source>Int J Sport Nutr Exerc Metab</source><year>2015</year><volume>25</volume><fpage>359</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1123/ijsnem.2014-0129</pub-id><pub-id pub-id-type="pmid">25811674</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masschelein</surname><given-names>E</given-names></name><name><surname>Van Thienen</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Van Schepdael</surname><given-names>A</given-names></name><name><surname>Thomis</surname><given-names>M</given-names></name><name><surname>Hespel</surname><given-names>P</given-names></name></person-group><article-title>Dietary nitrate improves muscle but not cerebral oxygenation status during exercise in hypoxia</article-title><source>J Appl Physiol</source><year>2012</year><volume>113</volume><fpage>736</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01253.2011</pub-id><pub-id pub-id-type="pmid">22773768</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>J</given-names></name><name><surname>Vanhatalo</surname><given-names>A</given-names></name><name><surname>Bailey</surname><given-names>SJ</given-names></name><name><surname>Wylie</surname><given-names>LJ</given-names></name><name><surname>Tucker</surname><given-names>C</given-names></name><name><surname>List</surname><given-names>S</given-names></name><name><surname>Winyard</surname><given-names>PG</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name></person-group><article-title>Dietary nitrate supplementation: effects on plasma nitrite and pulmonary O2 uptake dynamics during exercise in hypoxia and normoxia</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2014</year><volume>307</volume><fpage>R920</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00068.2014</pub-id><pub-id pub-id-type="pmid">25009219</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinity</surname><given-names>JD</given-names></name><name><surname>Pahnke</surname><given-names>MD</given-names></name><name><surname>Trombold</surname><given-names>JR</given-names></name><name><surname>Coyle</surname><given-names>EF</given-names></name></person-group><article-title>Impact of polyphenol antioxidants on cycling performance and cardiovascular function</article-title><source>Nutrients</source><year>2014</year><volume>6</volume><fpage>1273</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.3390/nu6031273</pub-id><pub-id pub-id-type="pmid">24667134</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govoni</surname><given-names>M</given-names></name><name><surname>Jansson</surname><given-names>EÅ</given-names></name><name><surname>Weitzberg</surname><given-names>E</given-names></name><name><surname>Lundberg</surname><given-names>JO</given-names></name></person-group><article-title>The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash</article-title><source>Nitric Oxide</source><year>2008</year><volume>19</volume><fpage>333</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2008.08.003</pub-id><pub-id pub-id-type="pmid">18793740</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>G</given-names></name></person-group><source>Borg’s perceived exertion and pain scales</source><year>1998</year><publisher-loc>Champaign</publisher-loc><publisher-name>Human Kinetics</publisher-name></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group><source>Statistical power analysis for the behavioral sciences</source><year>1988</year><edition>2</edition><publisher-loc>Hillsdale</publisher-loc><publisher-name>Lawrence Erlbaum</publisher-name></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trombold</surname><given-names>JR</given-names></name><name><surname>Reinfeld</surname><given-names>AS</given-names></name><name><surname>Casler</surname><given-names>JR</given-names></name><name><surname>Coyle</surname><given-names>EF</given-names></name></person-group><article-title>The effect of pomegranate juice supplementation on strength and soreness after eccentric exercise</article-title><source>J Strength Cond Res</source><year>2011</year><volume>25</volume><fpage>1782</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1519/JSC.0b013e318220d992</pub-id><pub-id pub-id-type="pmid">21659887</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">Machin DR, Christmas KM, Chou T-H, Hill SC, Van Pelt DW, Trombold JR, Coyle EF. Effects of differing dosages of pomegranate juice supplementation after eccentric exercise. Physiology J. 2014;2014:1–7.</mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Nyakayiru J, Jonvik KL, Pinckaers PJ, Senden J, Van Loon LJ, Verdijk LB. No effect of acute and 6-day nitrate supplementation on VO2 and time-trial performance in highly-trained cyclists. Int J Sport Nutr Exerc Metab. 2016;27:1–25.</mixed-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boorsma</surname><given-names>RK</given-names></name><name><surname>Whitfield</surname><given-names>J</given-names></name><name><surname>Spriet</surname><given-names>LL</given-names></name></person-group><article-title>Beetroot juice supplementation does not improve performance of elite 1500-m runners</article-title><source>Med Sci Sports Exerc</source><year>2014</year><volume>46</volume><fpage>2326</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1249/MSS.0000000000000364</pub-id><pub-id pub-id-type="pmid">24781895</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazimierczak</surname><given-names>R</given-names></name><name><surname>Hallmann</surname><given-names>E</given-names></name><name><surname>Lipowski</surname><given-names>J</given-names></name><name><surname>Drela</surname><given-names>N</given-names></name><name><surname>Kowalik</surname><given-names>A</given-names></name><name><surname>Püssa</surname><given-names>T</given-names></name><name><surname>Matt</surname><given-names>D</given-names></name><name><surname>Luik</surname><given-names>A</given-names></name><name><surname>Gozdowski</surname><given-names>D</given-names></name><name><surname>Rembiałkowska</surname><given-names>E</given-names></name></person-group><article-title>Beetroot (Beta vulgaris L.) and naturally fermented beetroot juices from organic and conventional production: metabolomics, antioxidant levels and anticancer activity</article-title><source>J Sci Food Agr</source><year>2014</year><volume>94</volume><fpage>2618</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1002/jsfa.6722</pub-id><pub-id pub-id-type="pmid">24798659</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAnulty</surname><given-names>SR</given-names></name><name><surname>McAnulty</surname><given-names>LS</given-names></name><name><surname>Nieman</surname><given-names>DC</given-names></name><name><surname>Quindry</surname><given-names>JC</given-names></name><name><surname>Hosick</surname><given-names>PA</given-names></name><name><surname>Hudson</surname><given-names>MH</given-names></name><name><surname>Still</surname><given-names>L</given-names></name><name><surname>Henson</surname><given-names>DA</given-names></name><name><surname>Milne</surname><given-names>GL</given-names></name><name><surname>Morrow</surname><given-names>JD</given-names></name></person-group><article-title>Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation</article-title><source>Appl Physiol Nutr Metab</source><year>2008</year><volume>33</volume><fpage>254</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1139/H07-177</pub-id><pub-id pub-id-type="pmid">18347680</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quindry</surname><given-names>JC</given-names></name><name><surname>McAnulty</surname><given-names>SR</given-names></name><name><surname>Hudson</surname><given-names>MB</given-names></name><name><surname>Hosick</surname><given-names>P</given-names></name><name><surname>Dumke</surname><given-names>C</given-names></name><name><surname>McAnulty</surname><given-names>LS</given-names></name><name><surname>Henson</surname><given-names>D</given-names></name><name><surname>Morrow</surname><given-names>JD</given-names></name><name><surname>Nieman</surname><given-names>D</given-names></name></person-group><article-title>Oral quercetin supplementation and blood oxidative capacity in response to ultramarathon competition</article-title><source>Int J Sport Nutr Exerc Metab</source><year>2008</year><volume>18</volume><fpage>601</fpage><pub-id pub-id-type="doi">10.1123/ijsnem.18.6.601</pub-id><pub-id pub-id-type="pmid">19164830</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>F</given-names></name><name><surname>Weitzberg</surname><given-names>E</given-names></name><name><surname>Lundberg</surname><given-names>J</given-names></name><name><surname>Ekblom</surname><given-names>B</given-names></name></person-group><article-title>Effects of dietary nitrate on oxygen cost during exercise</article-title><source>Acta Physiol</source><year>2007</year><volume>191</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1111/j.1748-1716.2007.01713.x</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>DP</given-names></name><name><surname>Madery</surname><given-names>BD</given-names></name><name><surname>Curry</surname><given-names>TB</given-names></name><name><surname>Eisenach</surname><given-names>JH</given-names></name><name><surname>Wilkins</surname><given-names>BW</given-names></name><name><surname>Joyner</surname><given-names>MJ</given-names></name></person-group><article-title>Nitric oxide contributes to the augmented vasodilatation during hypoxic exercise</article-title><source>J Physiol</source><year>2010</year><volume>588</volume><fpage>373</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2009.180489</pub-id><pub-id pub-id-type="pmid">19948661</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McConell</surname><given-names>GK</given-names></name><name><surname>Bradley</surname><given-names>SJ</given-names></name><name><surname>Stephens</surname><given-names>TJ</given-names></name><name><surname>Canny</surname><given-names>BJ</given-names></name><name><surname>Kingwell</surname><given-names>BA</given-names></name><name><surname>Lee-Young</surname><given-names>RS</given-names></name></person-group><article-title>Skeletal muscle nNOSμ protein content is increased by exercise training in humans</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2007</year><volume>293</volume><fpage>R821</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00796.2006</pub-id><pub-id pub-id-type="pmid">17459909</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassalle</surname><given-names>C</given-names></name><name><surname>Lubrano</surname><given-names>V</given-names></name><name><surname>Domenici</surname><given-names>C</given-names></name><name><surname>L’abbate</surname><given-names>A</given-names></name></person-group><article-title>Influence of chronic aerobic exercise on microcirculatory flow and nitric oxide in humans</article-title><source>Int Journal Sports Med</source><year>2003</year><volume>24</volume><fpage>30</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1055/s-2003-37202</pub-id><pub-id pub-id-type="pmid">12582949</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>L</given-names></name><name><surname>Bangsbo</surname><given-names>J</given-names></name><name><surname>Hellsten</surname><given-names>Y</given-names></name></person-group><article-title>Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle</article-title><source>J Physiol</source><year>2004</year><volume>557</volume><fpage>571</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2003.057711</pub-id><pub-id pub-id-type="pmid">15020701</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>SK</given-names></name><name><surname>Hirai</surname><given-names>DM</given-names></name><name><surname>Copp</surname><given-names>SW</given-names></name><name><surname>Holdsworth</surname><given-names>CT</given-names></name><name><surname>Allen</surname><given-names>JD</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name><name><surname>Musch</surname><given-names>TI</given-names></name><name><surname>Poole</surname><given-names>DC</given-names></name></person-group><article-title>Effects of nitrate supplementation via beetroot juice on contracting rat skeletal muscle microvascular oxygen pressure dynamics</article-title><source>Respir Physiol Neurobiol</source><year>2013</year><volume>187</volume><fpage>250</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2013.04.001</pub-id><pub-id pub-id-type="pmid">23584049</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holloszy</surname><given-names>JO</given-names></name><name><surname>Coyle</surname><given-names>EF</given-names></name></person-group><article-title>Adaptations of skeletal muscle to endurance exercise and their metabolic consequences</article-title><source>J Appl Physiol</source><year>1984</year><volume>56</volume><fpage>831</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">6373687</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanhatalo</surname><given-names>A</given-names></name><name><surname>Fulford</surname><given-names>J</given-names></name><name><surname>Bailey</surname><given-names>SJ</given-names></name><name><surname>Blackwell</surname><given-names>JR</given-names></name><name><surname>Winyard</surname><given-names>PG</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name></person-group><article-title>Dietary nitrate reduces muscle metabolic perturbation and improves exercise tolerance in hypoxia</article-title><source>J Physiol</source><year>2011</year><volume>589</volume><fpage>5517</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2011.216341</pub-id><pub-id pub-id-type="pmid">21911616</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thirup</surname><given-names>P</given-names></name></person-group><article-title>Haematocrit</article-title><source>Sports Med</source><year>2003</year><volume>3</volume><fpage>231</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.2165/00007256-200333030-00005</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilber</surname><given-names>RL</given-names></name></person-group><article-title>Application of altitude/hypoxic training by elite athletes</article-title><source>J Hum Sport Exerc</source><year>2011</year><volume>6</volume><fpage>271</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.4100/jhse.2011.62.07</pub-id></element-citation></ref></ref-list></back></article>